uric acid has been researched along with Arteriosclerosis, Coronary in 210 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Elevated serum uric acid (UA), a biomarker of renal insufficiency, is also an independent prognostic marker for morbidity in coronary artery disease (CAD) and poses serious health risks." | 9.22 | Almond supplementation reduces serum uric acid in coronary artery disease patients: a randomized controlled trial. ( Amin, F; Arslan, J; Ghani, S; Gilani, AU; Jamshed, H; Masroor, M; Sultan, FA, 2016) |
| " Of 2,963 patients with coronary artery disease enrolled in the Bezafibrate Infarction Prevention study, 1,410 had MS, as established by the presence of ≥3 of the following 5 criteria: serum fasting glucose >110 mg/dl, triglycerides >150 mg/dl, high-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women, systolic and diastolic blood pressures >130 and 80 mm Hg, respectively, and body mass index >28 kg/m²." | 9.14 | Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P, 2010) |
| "Studies on the association of uric acid with mortality and cardiovascular outcomes in patients with hypertension have produced contradictory results." | 9.12 | Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis. ( Jin, Z; Yang, Y; Zhang, X; Zhao, Q, 2021) |
| "Elevated serum uric acid (SUA) levels are associated with coronary artery disease (CAD)." | 8.31 | Correlation of elevated serum uric acid with coronary artery disease in Xinjiang, China: A retrospective case-control study. ( Fu, ZY; Ji, HY; Li, HY; Ma, YT; Maimaitituersun, G, 2023) |
| "Serum uric acid (UA) level is associated with the high cumulative incidence or prevalence of coronary artery disease (CAD), and hyperuricemia is considered as an independent risk marker for CAD." | 8.31 | Overnight changes in uric acid, xanthine oxidoreductase and oxidative stress levels and their relationships with sleep-disordered breathing in patients with coronary artery disease. ( Daida, H; Hiki, M; Ishiwata, S; Kasai, T; Kato, T; Kuwabara, M; Matsumoto, H; Murase, T; Murata, A; Naito, R; Nakamura, T; Sato, A; Shimizu, M; Shitara, J; Suda, S; Yatsu, S, 2023) |
| "Background Serum uric acid (UA) is correlated closely with traditional cardiovascular risk factors, which might interfere with the action of UA, in patients with coronary artery disease." | 8.31 | Uric Acid Levels, Number of Standard Modifiable Cardiovascular Risk Factors, and Prognosis in Patients With Coronary Artery Disease: A Large Cohort Study in Asia. ( Cui, K; Dong, Q; Dou, K; Feng, L; Fu, R; Jia, L; Lu, Y; Song, C; Song, W; Song, Y; Wang, H; Yang, Y; Yin, D; Zhang, D; Zhu, C, 2023) |
| " Thus, we aimed to investigate diurnal variations in serum levels of UA and plasma levels of xanthine, hypoxanthine, and xanthine oxidoreductase (XOR) activity, which were measured at 18:00, 6:00, and 12:00 in male patients with coronary artery disease." | 8.31 | Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease. ( Hiki, M; Ishiwata, S; Kasai, T; Kato, T; Kuwabara, M; Matsumoto, H; Murase, T; Murata, A; Naito, R; Nakamura, T; Sato, A; Shimizu, M; Shitara, J; Suda, S; Yatsu, S, 2023) |
| "The impact of serum uric acid (sUA) levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome (ACS) and hypertension after percutaneous coronary intervention (PCI) is not fully clear." | 8.12 | Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study. ( Liu, X; Shao, Y; Song, B; Yu, H; Zhang, S; Zhang, X, 2022) |
| "The association between serum uric acid (SUA) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in patients with coronary artery disease (CAD) is unclear." | 8.12 | Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure. ( Beatrice, G; Bonapace, S; Cappelli, D; Csermely, A; Dugo, C; Mantovani, A; Molon, G; Petracca, G; Targher, G, 2022) |
| "The association of serum uric acid (SUA) levels with cardiovascular outcomes in patients with coronary artery disease (CAD) has been extensively studied and yielded conflicting results." | 8.02 | Prognostic Significance of Uric Acid in Patients with Obstructive and Nonobstructive Coronary Artery Disease Undergoing D-SPECT. ( Abdu, FA; Che, W; Feng, C; Liu, L; Lv, X; Mohammed, AQ; Shi, T; Xu, S; Yin, G, 2021) |
| "Serum uric acid (SUA) levels have been reported to be associated with an increased risk of coronary artery disease (CAD) among patients with diabetes in observational study." | 8.02 | Genetically predicted serum uric acid levels and the risk of coronary artery disease in patients with diabetes: A Mendelian randomization study. ( Chen, S; Fu, G; Wang, Y; Xu, T; Yang, F; Zhang, K; Zhang, W, 2021) |
| "Serum uric acid (SUA) is a heritable trait associated with cardiovascular risk factors and coronary artery disease (CAD)." | 7.91 | Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease. ( Acuña-Alonzo, V; Aguilar-Salinas, CA; Barranco Garduño, LM; Bedoya, G; Bortolini, MC; Canizales-Quinteros, S; Carrasco-Portugal, MDC; Del-Río-Navarro, BE; Fernández Del Valle-Laisequilla, C; Flores-Murrieta, FJ; Gallo, C; González-Jose, R; Jacobo-Albavera, L; León-Mimila, P; López-Contreras, BE; Macias-Kauffer, LR; Morán-Ramos, S; Posadas-Romero, C; Posadas-Sánchez, R; Reyes-García, JG; Romero-Hidalgo, S; Rothhammer, F; Ruiz-Linares, A; Stephens, CR; Vargas-Alarcón, G; Velazquez-Cruz, R; Villamil-Ramírez, H; Villarreal-Molina, T, 2019) |
| "The association between uric acid (UA) and coronary artery disease (CAD) was controversial." | 7.91 | Association between serum uric acid levels and coronary artery disease in different age and gender: a cross-sectional study. ( Chen, L; Li, J; Qi, G; Shi, L; Sun, Y; Tian, W; Zhang, H; Zhao, S, 2019) |
| "This study has been undertaken to determine and compare the levels of serum uric acid in cases with and without coronary artery disease (CAD), to study association between serum uric acid (SUA) level with presence and severity of coronary artery disease." | 7.91 | Association between Serum Uric Acid Level with Presence and Severity of Coronary Artery Disease. ( Deotale, R; Kumbhalkar, S, 2019) |
| "Uric acid (UA) has been associated with the presence and severity of coronary artery disease." | 7.88 | The association between uric acid levels and different clinical manifestations of coronary artery disease. ( Antonsen, S; Diederichsen, ACP; Gerke, O; Lambrechtsen, J; Larsen, TR; Mickley, H; Saaby, L; Sand, NP; Steffensen, FH, 2018) |
| "The role of serum uric acid in coronary artery disease has been extensively investigated." | 7.88 | Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome. ( Alessandrini, M; Barraud, J; Bonello, L; Cautela, J; Fenouillet, E; Fromonot, J; Gaubert, M; Guieu, R; Laine, M; Marlinge, M; Mottola, G; Paganelli, F; Rossi, P; Ruf, J; Thuny, F, 2018) |
| "Elderly, hospitalized coronary artery disease patients on regular aspirin treatment were enrolled from January 2014 to September 2016." | 7.85 | Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease. ( Chen, XH; Feng, XR; Fu, SW; He, XQ; Liang, WY; Liu, ML; Liu, WW; McCaffrey, TA; Zhang, JW, 2017) |
| "Uric acid is a risk factor for coronary artery disease in postmenopausal women, but the association with inflammation and coronary endothelial dysfunction (CED) is not well defined." | 7.85 | Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women. ( Gulati, R; Herrmann, J; Lerman, A; Lerman, LO; Matteson, EL; Prasad, M; Rihal, CS, 2017) |
| "The importance and function of serum uric acid (UA) levels in patients with cardiovascular disease or stroke are unclear." | 7.83 | Prognostic Significance of Uric Acid Levels in Ischemic Stroke Patients. ( Cao, YJ; Huang, ZC; Liu, CF; Lu, TS; You, SJ; Zhang, X, 2016) |
| "The role of hyperhomocysteinemia in coronary artery disease (CAD) patients remains unclear." | 7.83 | Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease. ( Bonatti, S; Bruzzese, L; Cuisset, T; Deharo, P; Fenouillet, E; Fromonot, J; Guieu, R; Mottola, G; Quilici, J; Ruf, J, 2016) |
| "Several studies have investigated the association between serum uric acid (SUA) and the risks of coronary artery disease (CAD) but have yielded inconsistent results." | 7.83 | Association between Serum Uric Acid and Mortality among Chinese Patients with Coronary Artery Disease. ( Chen, Q; Ding, D; Hong, C; Li, Q; Li, X; Ling, W; Liu, C; Yang, Y; Zhang, Y, 2016) |
| "Serum uric acid (SUA) has been established to be highly associated with coronary artery disease (CAD) susceptibility and lipid metabolism, but the underlying mechanisms are unclear." | 7.81 | Lipoprotein subfractions partly mediate the association between serum uric acid and coronary artery disease. ( Guo, YL; Li, JJ; Li, S; Sun, J; Xu, RX; Zhang, Y; Zhu, CG, 2015) |
| "To confirm the possible relationships between serum level of uric acid (UA) and benign paroxysmal positional vertigo (BPPV)." | 7.81 | [Relationship between serum level of uric acid and benign paroxysmal positional vertigo]. ( Chen, Y; Dong, Q; Hu, W; Li, S; Niu, S; Yuan, J, 2015) |
| "Serum uric acid (SUA) levels have been proposed as a biomarker of coronary artery disease (CAD) and coronary collateral circulation (CCC)." | 7.80 | Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. ( Cayli, M; Duran, M; Elbasan, Z; Gur, M; Kaya, MG; Kunak, AU; Ozkan, B; Sahin, DY; Tekin, K; Turkoglu, C; Uysal, OK; Yildirim, A; Yilmaz, Y, 2014) |
| " Uric acid is also associated with endothelial dysfunction, oxidative stress, and CVD, raising the hypothesis that an increased serum uric acid might predict ED in patients who are at risk for coronary artery disease (CAD)." | 7.80 | Uric acid level and erectile dysfunction in patients with coronary artery disease. ( Akilli, H; Aribas, A; Covic, A; Gaipov, A; Johnson, RJ; Kanbay, M; Kayrak, M; McFann, K; Perez-Pozo, SE; Solak, Y; Turk, S, 2014) |
| "Serum uric acid (SUA) elevation has been associated with the main determinants of atherosclerosis and metabolic syndrome, although an independent relationship between SUA and coronary artery disease (CAD) has never been confirmed." | 7.80 | Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study. ( Aimaretti, G; Barbieri, L; Bellomo, G; Cassetti, E; De Luca, G; Marino, P; Nardin, M; Schaffer, A; Sinigaglia, F; Verdoia, M, 2014) |
| "Although many studies have examined the relationship between uric acid (UA) and coronary artery disease (CAD), whether UA is an independent risk factor contributing to progression of CAD is still controversial." | 7.80 | A cross-sectional analysis of the relationship between uric acid and coronary atherosclerosis in patients with suspected coronary artery disease in China. ( Chen, L; Geng, S; Li, H; Liu, T; Qi, G; Sun, Y; Wu, C; Xu, K; Yu, X; Zhi, Y, 2014) |
| "To date, no study in the published literature has investigated the role of various serum uric acid (SUA) concentrations in the development of angiographically-proven coronary artery disease (CAD) in premenopausal women." | 7.80 | Association of serum uric acid and coronary artery disease in premenopausal women. ( Cao, SJ; He, LJ; Yang, Q; Yang, SW; Zhang, JW; Zhou, YJ, 2014) |
| "The optimal uric acid (UA) level associated with the lowest mortality and the strength of association between UA and mortality in various subgroups of patients with coronary artery disease (CAD) are unknown." | 7.79 | Uric acid and prognosis in angiography-proven coronary artery disease. ( Braun, S; Cassese, S; Fusaro, M; Haase, HU; Hadamitzky, M; Kastrati, A; King, L; Ndrepepa, G; Schömig, A; Tada, T, 2013) |
| "Our study showed that uric acid is not associated with platelet aggregation, the extent of coronary artery disease and IMT." | 7.78 | Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. ( Bellomo, G; Cassetti, E; Coppo, L; De Luca, G; Di Mario, C; Iorio, S; Marino, P; Santagostino, M; Secco, GG; Venegoni, L; Verdoia, M, 2012) |
| "Serum uric acid (SUA) is a potential risk factor for atherosclerosis." | 7.78 | Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. ( Bian, L; Choi, Y; Zhang, Z, 2012) |
| "We aimed to elucidate the relation between serum uric acid (SUA) level and severity of coronary artery disease (CAD) in nondiabetic, nonhypertensive patients (n = 246) with acute coronary syndrome (ACS)." | 7.78 | High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. ( Akpek, M; Duran, M; Elcik, D; Ergin, A; Eryol, NK; Inanc, MT; Kalay, N; Kasapkara, HA; Kaya, MG; Ocak, A; Oguzhan, A; Orscelik, O, 2012) |
| "To examine the association between renal function, serum uric acid and markers of both pro-inflammatory and prothrombotic state in patients with diabetes mellitus (DM), metabolic syndrome and coronary artery disease." | 7.77 | Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. ( Buraczyńska, MJ; Kondracki, B; Rychta, E; Waciński, P; Wysokiński, A; Zapolski, T, 2011) |
| "High serum uric acid (SUA) has been well demonstrated to be associated with morbidity and mortality in the general population as well as in patients with coronary artery disease (CAD)." | 7.77 | Predictors of clinical SYNTAX score in coronary artery disease: serum uric acid, smoking, and Framingham risk stratification. ( Chen, L; Qian, X; Wu, Z; Xiong, Z; Zhu, C; Zhu, J, 2011) |
| "Although increased serum uric acid (SUA) concentrations are commonly encountered in patients with risk factors for coronary artery disease (CAD), the clinical value of SUA has not been established." | 7.76 | Clinical value of serum uric Acid in patients with suspected coronary artery disease. ( Kim, EJ; Kim, JW; Kim, SH; Lim, HE; Park, CG; Rha, SW; Seo, HS, 2010) |
| "This study was designed to determine the relationship between serum uric acid level and the presence and severity of coronary artery disease (CAD)." | 7.76 | The association between serum uric acid level and coronary artery disease. ( Aksoy, H; Aytemir, K; Baris Kaya, E; Evranos, B; Kabakci, G; Okutucu, S; Oto, A; Sinan Deveci, O; Tokgozoglu, L; Tulumen, E, 2010) |
| "To discuss the relationship between high sensitive C-reactive protein (hs-CRP), lipoprotein (Lp)(a), blood uric acid (BUA) and severity of coronary artery disease (CHD)." | 7.76 | [Correlation between high sensitive C-reactive protein, lipoprotein(a), blood uric acid and severity of coronary artery disease]. ( Chen, XL; Ding, YP; He, P; Xie, XH, 2010) |
| "Combined assessment of serum uric acid (UA) and C-reactive protein (CRP) compared with single-marker evaluation in patients with coronary artery disease (CAD) was performed." | 7.75 | Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study). ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P; Goldenberg, I, 2009) |
| "In patients with coronary artery disease (CAD), elevated serum uric acid (SUA) levels may predict worse cardiovascular outcomes." | 7.75 | Serum uric acid for risk stratification of patients with coronary artery disease. ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P; Goldenberg, I; Mandelzweig, L, 2009) |
| "Serum uric acid concentrations are higher in patients with established coronary artery disease than in healthy controls." | 7.74 | The relationship between coronary artery disease and uric acid levels in young patients with acute myocardial infarction. ( Aktoz, M; Altun, A; Buyuklu, M; Tatli, E, 2008) |
| "We examined the associations of serum uric acid (UA) with indices of coronary heart disease (CHD) risk, including the 10-year probability of CHD (10y-CHDr), metabolic syndrome (MS), inflammation (C-reactive protein [CRP] and fibrinogen), and the presence and quantity of coronary artery calcium (CAC)." | 7.74 | Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. ( Bielak, LF; Coutinho, Tde A; Kullo, IJ; Peyser, PA; Sheedy, PF; Turner, ST, 2007) |
| "Epidemiological studies have shown that a high serum uric acid concentration is a risk factor for coronary artery disease (CAD)." | 7.74 | Independent association of high serum uric acid concentration with angiographically defined coronary artery disease. ( Bogavac-Stanojević, N; Jelić-Ivanović, Z; Memon, L; Spasić, S; Spasojević-Kalimanovska, V, 2007) |
| "Gout and increased serum uric acid (SUA) levels are often seen in patients with components of the metabolic syndrome." | 7.74 | Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. ( Algra, A; Hjortnaes, J; Huisman, M; Jacobs, J; Olijhoek, J; van der Graaf, Y; Visseren, F, 2007) |
| "Plasma total homocysteine, uric acid and allantoin levels of 50 patients with coronary artery diseases and 23 healthy controls were determined by HPLC methods." | 7.73 | Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation. ( Imren, E; Ozkan, Y; Simşek, B; Torun, M; Yardim-Akaydin, S, 2006) |
| "It is a matter of controversy as to whether uric acid is an independent predictor of mortality in patients with coronary artery disease (CAD) or whether it represents only an indirect marker of adverse outcome by reflecting the association between uric acid and other cardiovascular risk factors." | 7.71 | Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. ( Bickel, C; Blankenberg, S; Daunhauer, A; Hafner, G; Hofmann, KP; Meyer, J; Rippin, G; Rupprecht, HJ, 2002) |
| "Comparison of the serum uric acid levels of healthy people (n=71) and patients with cardiovascular diseases (CVD) (n=62)." | 7.70 | Serum uric acid levels in cardiovascular diseases. ( Burgaz, S; Simsek, B; Torun, M; Yardim, S, 1998) |
| "Uric Acid (UA) has been related to the development of Cardio-Vascular (CV) events in patients affected by Chronic Coronary Syndromes (CCS)." | 5.62 | Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular diastolic parameter. ( Bossi, I; De Chiara, B; Giannattasio, C; Maloberti, A; Moreo, A; Nava, S; Oliva, F; Oreglia, J; Piccalò, G; Piccaluga, E; Pirola, R; Racioppi, A; Rebora, P; Soriano, F; Tassistro, E; Vallerio, P; Valsecchi, MG, 2021) |
| "Hyperuricemia is independently associated with cardiovascular disease (CVD) and is considered to be one of the major risk factors for CVD." | 5.56 | Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention. ( Chan, WL; Charng, MJ; Chen, JW; Chen, SC; Chen, YH; Cheng, HM; Chou, CY; Hsu, PF; Huang, CC; Huang, PH; Huang, SS; Leu, HB; Lim, SS; Lin, SJ; Lin, YJ; Lu, TM; Pan, JP; Sung, SH; Wu, CH; Wu, TC; Yang, YL, 2020) |
| "Allopurinol is a urate-lowering therapy used to treat patients with gout." | 5.51 | Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. ( Avery, AJ; Barr, RJ; Begg, AG; Duce, SL; Dumbleton, JS; Ford, I; Greenlaw, N; Hawkey, CJ; MacDonald, TM; Mackenzie, IS; Pigazzani, F; Ritchie, LD; Rogers, A; Rooke, ED; Struthers, AD; Taggar, JS; Townend, JN; Walker, A; Wei, L, 2022) |
| "In conclusion, in patients with Type 2 diabetes mellitus and confirmed CAD, elevated levels of UA predict mortality independently of known cardiovascular risk factors." | 5.39 | Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. ( Braun, S; Cassese, S; Fusaro, M; Haase, HU; Hadamitzky, M; Kastrati, A; King, L; Ndrepepa, G; Schömig, A; Tada, T, 2013) |
| "Uric acid was measured before angiography." | 5.38 | Association of uric acid with mortality in patients with stable coronary artery disease. ( Birkmeier, KA; Braun, S; Haase, HU; Hadamitzky, M; Kastrati, A; King, L; Ndrepepa, G; Schömig, A, 2012) |
| "Elevated serum uric acid (UA), a biomarker of renal insufficiency, is also an independent prognostic marker for morbidity in coronary artery disease (CAD) and poses serious health risks." | 5.22 | Almond supplementation reduces serum uric acid in coronary artery disease patients: a randomized controlled trial. ( Amin, F; Arslan, J; Ghani, S; Gilani, AU; Jamshed, H; Masroor, M; Sultan, FA, 2016) |
| "Forty-seven patients with multiple cardiovascular risk factors, nonobstructive coronary artery disease, and coronary endothelial dysfunction were randomized in a double-blind manner to either the ET(A) receptor antagonist atrasentan (10 mg) or placebo for 6 months." | 5.14 | Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. ( Lennon, R; Lerman, A; Lerman, LO; Mathew, V; Nelson, RE; Prasad, A; Pumper, GM; Raichlin, E; Reriani, M; Rihal, C, 2010) |
| " Of 2,963 patients with coronary artery disease enrolled in the Bezafibrate Infarction Prevention study, 1,410 had MS, as established by the presence of ≥3 of the following 5 criteria: serum fasting glucose >110 mg/dl, triglycerides >150 mg/dl, high-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women, systolic and diastolic blood pressures >130 and 80 mm Hg, respectively, and body mass index >28 kg/m²." | 5.14 | Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P, 2010) |
| " It was our aim to compare the impact of exercise training with that of rosiglitazone on endothelial function and inflammatory markers in patients with IGT and coronary artery disease (CAD)." | 5.13 | Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease. ( Desch, S; Niebauer, J; Rastan, A; Schmidt, A; Schuler, G; Sixt, S; Sonnabend, M, 2008) |
| "Studies on the association of uric acid with mortality and cardiovascular outcomes in patients with hypertension have produced contradictory results." | 5.12 | Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis. ( Jin, Z; Yang, Y; Zhang, X; Zhao, Q, 2021) |
| "Hyperuricemia coincides with coronary artery calcification (CAC) development, but the role of serum uric acid (SUA) as a risk factor for CAC remains unclear." | 5.01 | The association between hyperuricemia and coronary artery calcification development: A systematic review and meta-analysis. ( Bainey, KR; Banh, HL; Hou, X; Li, W; Liang, L; Qi, Z; Tymchak, W; Zhang, Y, 2019) |
| "Elevated serum uric acid (SUA) levels are associated with coronary artery disease (CAD)." | 4.31 | Correlation of elevated serum uric acid with coronary artery disease in Xinjiang, China: A retrospective case-control study. ( Fu, ZY; Ji, HY; Li, HY; Ma, YT; Maimaitituersun, G, 2023) |
| "Serum uric acid (UA) level is associated with the high cumulative incidence or prevalence of coronary artery disease (CAD), and hyperuricemia is considered as an independent risk marker for CAD." | 4.31 | Overnight changes in uric acid, xanthine oxidoreductase and oxidative stress levels and their relationships with sleep-disordered breathing in patients with coronary artery disease. ( Daida, H; Hiki, M; Ishiwata, S; Kasai, T; Kato, T; Kuwabara, M; Matsumoto, H; Murase, T; Murata, A; Naito, R; Nakamura, T; Sato, A; Shimizu, M; Shitara, J; Suda, S; Yatsu, S, 2023) |
| "In the present study, we investigated the association between risk factors for atherosclerosis [including HU, HTN, blood pressure and serum uric acid (UA) levels] and paroxysmal atrial fibrillation (Paro-AF) or persistent atrial fibrillation (Pers-AF) in patients who underwent coronary computed tomography angiography (CCTA)." | 4.31 | Association between paroxysmal or persistent atrial fibrillation and hyperuricemia in patients who underwent coronary computed tomography angiography: from the FU-CCTA-AF Registry. ( Higashi, S; Ideishi, A; Kawahira, Y; Komaki, T; Mikagi, M; Miura, SI; Ogawa, M; Shiga, Y; Suematsu, Y; Tachibana, T; Tashiro, K, 2023) |
| "Background Serum uric acid (UA) is correlated closely with traditional cardiovascular risk factors, which might interfere with the action of UA, in patients with coronary artery disease." | 4.31 | Uric Acid Levels, Number of Standard Modifiable Cardiovascular Risk Factors, and Prognosis in Patients With Coronary Artery Disease: A Large Cohort Study in Asia. ( Cui, K; Dong, Q; Dou, K; Feng, L; Fu, R; Jia, L; Lu, Y; Song, C; Song, W; Song, Y; Wang, H; Yang, Y; Yin, D; Zhang, D; Zhu, C, 2023) |
| " Thus, we aimed to investigate diurnal variations in serum levels of UA and plasma levels of xanthine, hypoxanthine, and xanthine oxidoreductase (XOR) activity, which were measured at 18:00, 6:00, and 12:00 in male patients with coronary artery disease." | 4.31 | Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease. ( Hiki, M; Ishiwata, S; Kasai, T; Kato, T; Kuwabara, M; Matsumoto, H; Murase, T; Murata, A; Naito, R; Nakamura, T; Sato, A; Shimizu, M; Shitara, J; Suda, S; Yatsu, S, 2023) |
| "Serum uric acid is positively correlated with Gensini score in patients with coronary heart disease, which is an independent factor for evaluating the degree of coronary artery stenosis and has a predictive effect." | 4.31 | Uric acid and evaluate the coronary vascular stenosis gensini score correlation research and in gender differences. ( Luo, Y; Ma, K; Mao, M; Wu, F; Xiang, R; Yang, B; Yang, G, 2023) |
| "The impact of serum uric acid (sUA) levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome (ACS) and hypertension after percutaneous coronary intervention (PCI) is not fully clear." | 4.12 | Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study. ( Liu, X; Shao, Y; Song, B; Yu, H; Zhang, S; Zhang, X, 2022) |
| "The association between serum uric acid (SUA) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in patients with coronary artery disease (CAD) is unclear." | 4.12 | Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure. ( Beatrice, G; Bonapace, S; Cappelli, D; Csermely, A; Dugo, C; Mantovani, A; Molon, G; Petracca, G; Targher, G, 2022) |
| "Background and Objectives: Although previous studies showed that an activity of xanthine oxidoreductase (XOR), a rate-limiting enzyme in purine metabolism, beyond the serum uric acid level, was associated with the development of coronary artery disease (CAD), the underlying mechanisms are unclear." | 4.12 | Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease. ( Akari, S; Hiraga, T; Kitahara, H; Kobayashi, Y; Mori, N; Murase, T; Nakamura, T; Saito, K; Saito, Y; Tateishi, K, 2022) |
| "The role of serum uric acid (SUA) as an independent risk factor for coronary artery disease remains unclear." | 4.02 | Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention. ( Kurozumi, M; Matsumoto, I; Moriya, S; Namba, T; Takagi, Y, 2021) |
| "The association of serum uric acid (SUA) levels with cardiovascular outcomes in patients with coronary artery disease (CAD) has been extensively studied and yielded conflicting results." | 4.02 | Prognostic Significance of Uric Acid in Patients with Obstructive and Nonobstructive Coronary Artery Disease Undergoing D-SPECT. ( Abdu, FA; Che, W; Feng, C; Liu, L; Lv, X; Mohammed, AQ; Shi, T; Xu, S; Yin, G, 2021) |
| "Serum uric acid (SUA) levels have been reported to be associated with an increased risk of coronary artery disease (CAD) among patients with diabetes in observational study." | 4.02 | Genetically predicted serum uric acid levels and the risk of coronary artery disease in patients with diabetes: A Mendelian randomization study. ( Chen, S; Fu, G; Wang, Y; Xu, T; Yang, F; Zhang, K; Zhang, W, 2021) |
| "We hypothesized that biomarkers and dietary factors related to cardiovascular disease risk were associated with serum retinol and evaluated these potential associations in patients with suspected coronary artery disease (CAD)." | 3.96 | Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease. ( Blomhoff, R; Dhar, I; Drevon, CA; Lysne, V; Midttun, Ø; Nygård, OK; Olsen, T; Pedersen, EKR; Refsum, H; Svingen, GFT; Ueland, PM; Vinknes, KJ, 2020) |
| "To investigate the correlation between uric acid (UA) and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and coronary artery severity in acute coronary syndrome patients of different sexes." | 3.96 | Sex differences in uric acid and NT-pro BNP assessments during coronary severity. ( Chen, X; Guo, G; Huang, Z; Wang, S, 2020) |
| "Serum uric acid (SUA) level was shown in various studies to be related to the presence of coronary artery disease and subsequent cardiovascular events." | 3.91 | Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease. ( Atalay, E; Burak, C; Çağdaş, M; Çağdaş, ÖS; Gürsoy, MO; Karabağ, Y; Karakoyun, S; Rencuzogullari, I; Tanboğa, HI; Yesin, M, 2019) |
| "Serum uric acid (SUA) is a heritable trait associated with cardiovascular risk factors and coronary artery disease (CAD)." | 3.91 | Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease. ( Acuña-Alonzo, V; Aguilar-Salinas, CA; Barranco Garduño, LM; Bedoya, G; Bortolini, MC; Canizales-Quinteros, S; Carrasco-Portugal, MDC; Del-Río-Navarro, BE; Fernández Del Valle-Laisequilla, C; Flores-Murrieta, FJ; Gallo, C; González-Jose, R; Jacobo-Albavera, L; León-Mimila, P; López-Contreras, BE; Macias-Kauffer, LR; Morán-Ramos, S; Posadas-Romero, C; Posadas-Sánchez, R; Reyes-García, JG; Romero-Hidalgo, S; Rothhammer, F; Ruiz-Linares, A; Stephens, CR; Vargas-Alarcón, G; Velazquez-Cruz, R; Villamil-Ramírez, H; Villarreal-Molina, T, 2019) |
| "The association between uric acid (UA) and coronary artery disease (CAD) was controversial." | 3.91 | Association between serum uric acid levels and coronary artery disease in different age and gender: a cross-sectional study. ( Chen, L; Li, J; Qi, G; Shi, L; Sun, Y; Tian, W; Zhang, H; Zhao, S, 2019) |
| "This study has been undertaken to determine and compare the levels of serum uric acid in cases with and without coronary artery disease (CAD), to study association between serum uric acid (SUA) level with presence and severity of coronary artery disease." | 3.91 | Association between Serum Uric Acid Level with Presence and Severity of Coronary Artery Disease. ( Deotale, R; Kumbhalkar, S, 2019) |
| "Uric acid (UA) has been associated with the presence and severity of coronary artery disease." | 3.88 | The association between uric acid levels and different clinical manifestations of coronary artery disease. ( Antonsen, S; Diederichsen, ACP; Gerke, O; Lambrechtsen, J; Larsen, TR; Mickley, H; Saaby, L; Sand, NP; Steffensen, FH, 2018) |
| "The role of serum uric acid in coronary artery disease has been extensively investigated." | 3.88 | Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome. ( Alessandrini, M; Barraud, J; Bonello, L; Cautela, J; Fenouillet, E; Fromonot, J; Gaubert, M; Guieu, R; Laine, M; Marlinge, M; Mottola, G; Paganelli, F; Rossi, P; Ruf, J; Thuny, F, 2018) |
| "The aim of the study was to assess the independent contribution of hyperuricemia to coronary artery disease (CAD) confirmed by coronary angiography (CAG), and to explore associations between serum uric acid (SUA) level and CAD." | 3.88 | Evaluation of the association between hyperuricemia and coronary artery disease: A STROBE-compliant article. ( He, Q; Lan, M; Liu, B, 2018) |
| "Elderly, hospitalized coronary artery disease patients on regular aspirin treatment were enrolled from January 2014 to September 2016." | 3.85 | Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease. ( Chen, XH; Feng, XR; Fu, SW; He, XQ; Liang, WY; Liu, ML; Liu, WW; McCaffrey, TA; Zhang, JW, 2017) |
| "Uric acid is a risk factor for coronary artery disease in postmenopausal women, but the association with inflammation and coronary endothelial dysfunction (CED) is not well defined." | 3.85 | Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women. ( Gulati, R; Herrmann, J; Lerman, A; Lerman, LO; Matteson, EL; Prasad, M; Rihal, CS, 2017) |
| " Cox regression analysis showed that the baseline clinical and biochemical variables which associated with MACE were age, being illiterate, a widow or widower, and/or economically dependent, having triple vessel disease, stent implantation, anemia, and/or diabetes mellitus, waist to hip ratio (WHR), diastolic blood pressure, fasting glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), creatinine, estimated glomerular filtration rate (eGFR), red blood cell count, hemoglobin, hematocrit, and mean corpuscular-hemoglobin concentration (MCHC) in ACS patients, and age, malnourished, and/or economically dependent, taking hypoglycemic medication, having triple vessel disease, stent implantation, anemia, diabetes mellitus, and/or hypertension, WHR, fasting glucose, HDL-C, uric acid, creatinine, eGFR, high-sensitivity C-reactive protein, mean corpuscular volume, and MCHC in elective PCI patients." | 3.85 | The burden of major adverse cardiac events in patients with coronary artery disease. ( Chung, FM; Hsu, CC; Hung, WC; Lee, YJ; Lu, LF; Lu, YC; Tsai, IT; Wang, CP; Wu, CC; Yu, TH, 2017) |
| "The importance and function of serum uric acid (UA) levels in patients with cardiovascular disease or stroke are unclear." | 3.83 | Prognostic Significance of Uric Acid Levels in Ischemic Stroke Patients. ( Cao, YJ; Huang, ZC; Liu, CF; Lu, TS; You, SJ; Zhang, X, 2016) |
| " As hyperuricemia activates platelet turnover, aspirin resistance may be specifically induced by increased serum uric acid (SUA) levels." | 3.83 | Does high serum uric acid level cause aspirin resistance? ( Alihanoglu, YI; Bilgin, M; Ergin, A; Esin, F; Evrengul, H; Kaftan, HA; Kilic, ID; Ozkan, E; Ozkan, H; Yildiz, BS, 2016) |
| "In this cross-sectional study, consecutive inpatients with a non-ST elevation acute coronary event and asymptomatic hyperuricemia (serum uric acid concentration of ≥7." | 3.83 | Silent Monosodium Urate Crystal Deposits Are Associated With Severe Coronary Calcification in Asymptomatic Hyperuricemia: An Exploratory Study. ( Andrés, M; Pascual, E; Quintanilla, MA; Ruiz-Nodar, JM; Sánchez-Payá, J; Sivera, F; Vela, P, 2016) |
| "The role of hyperhomocysteinemia in coronary artery disease (CAD) patients remains unclear." | 3.83 | Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease. ( Bonatti, S; Bruzzese, L; Cuisset, T; Deharo, P; Fenouillet, E; Fromonot, J; Guieu, R; Mottola, G; Quilici, J; Ruf, J, 2016) |
| " Serum uric acid (SUA) has been largely addressed in the past as a possible risk factor for coronary artery disease, with a possible association with platelets hyperreactivity." | 3.83 | Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor. ( Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Suryapranata, H; Verdoia, M, 2016) |
| "Several studies have investigated the association between serum uric acid (SUA) and the risks of coronary artery disease (CAD) but have yielded inconsistent results." | 3.83 | Association between Serum Uric Acid and Mortality among Chinese Patients with Coronary Artery Disease. ( Chen, Q; Ding, D; Hong, C; Li, Q; Li, X; Ling, W; Liu, C; Yang, Y; Zhang, Y, 2016) |
| "New antithrombotic therapies have significantly improved the outcomes of patients with acute coronary syndrome (ACS), where the introduction of ticagrelor has provided the greatest mortality benefits." | 3.83 | Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study. ( Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Schaffer, A; Suryapranata, H; Verdoia, M, 2016) |
| "Serum uric acid (SUA) has been established to be highly associated with coronary artery disease (CAD) susceptibility and lipid metabolism, but the underlying mechanisms are unclear." | 3.81 | Lipoprotein subfractions partly mediate the association between serum uric acid and coronary artery disease. ( Guo, YL; Li, JJ; Li, S; Sun, J; Xu, RX; Zhang, Y; Zhu, CG, 2015) |
| "To confirm the possible relationships between serum level of uric acid (UA) and benign paroxysmal positional vertigo (BPPV)." | 3.81 | [Relationship between serum level of uric acid and benign paroxysmal positional vertigo]. ( Chen, Y; Dong, Q; Hu, W; Li, S; Niu, S; Yuan, J, 2015) |
| "The aim of the study was to investigate the effects of serum uric acid (SUA) on acute kidney injury (AKI) in patients undergoing cardiac surgery." | 3.81 | Effects of Serum Uric Acid on Estimated GFR in Cardiac Surgery Patients: A Pilot Study. ( Alquadan, KF; Dass, B; Ejaz, AA; Johnson, RJ; Kanbay, M; Shimada, M, 2015) |
| "Serum uric acid (SUA) levels have been proposed as a biomarker of coronary artery disease (CAD) and coronary collateral circulation (CCC)." | 3.80 | Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. ( Cayli, M; Duran, M; Elbasan, Z; Gur, M; Kaya, MG; Kunak, AU; Ozkan, B; Sahin, DY; Tekin, K; Turkoglu, C; Uysal, OK; Yildirim, A; Yilmaz, Y, 2014) |
| " Uric acid is also associated with endothelial dysfunction, oxidative stress, and CVD, raising the hypothesis that an increased serum uric acid might predict ED in patients who are at risk for coronary artery disease (CAD)." | 3.80 | Uric acid level and erectile dysfunction in patients with coronary artery disease. ( Akilli, H; Aribas, A; Covic, A; Gaipov, A; Johnson, RJ; Kanbay, M; Kayrak, M; McFann, K; Perez-Pozo, SE; Solak, Y; Turk, S, 2014) |
| "Serum uric acid (SUA) elevation has been associated with the main determinants of atherosclerosis and metabolic syndrome, although an independent relationship between SUA and coronary artery disease (CAD) has never been confirmed." | 3.80 | Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study. ( Aimaretti, G; Barbieri, L; Bellomo, G; Cassetti, E; De Luca, G; Marino, P; Nardin, M; Schaffer, A; Sinigaglia, F; Verdoia, M, 2014) |
| "The aim of this study was to investigate the effects of pravastatin and nebivolol in the atherosclerotic process including inflammation and oxidative stress in rat aorta." | 3.80 | The anti-inflammatory and antioxidant effects of pravastatin and nebivolol in rat aorta. ( Aktaş, SG; Atay, A; Çuhadar, S; Dursun, S; Köseoğlu, M, 2014) |
| "Although many studies have examined the relationship between uric acid (UA) and coronary artery disease (CAD), whether UA is an independent risk factor contributing to progression of CAD is still controversial." | 3.80 | A cross-sectional analysis of the relationship between uric acid and coronary atherosclerosis in patients with suspected coronary artery disease in China. ( Chen, L; Geng, S; Li, H; Liu, T; Qi, G; Sun, Y; Wu, C; Xu, K; Yu, X; Zhi, Y, 2014) |
| "To date, no study in the published literature has investigated the role of various serum uric acid (SUA) concentrations in the development of angiographically-proven coronary artery disease (CAD) in premenopausal women." | 3.80 | Association of serum uric acid and coronary artery disease in premenopausal women. ( Cao, SJ; He, LJ; Yang, Q; Yang, SW; Zhang, JW; Zhou, YJ, 2014) |
| "MPV, GGT and uric acid levels were significantly higher in subjects with stenotic coronary artery disease (CAD) and in subjects with both CAD and CAE compared with subjects with isolated CAE and subjects with normal coronary arteries (NCA)." | 3.79 | No relevant association between coronary artery ectasia and mean platelet volume, gamma-glutamyltransferase and uric acid levels. ( Akpek, M; Arınç, H; Baktır, AO; Karadağ, Z; Katlandur, H; Kaya, MG; Kurtul, S; Sağlam, H; Sarlı, B, 2013) |
| "The optimal uric acid (UA) level associated with the lowest mortality and the strength of association between UA and mortality in various subgroups of patients with coronary artery disease (CAD) are unknown." | 3.79 | Uric acid and prognosis in angiography-proven coronary artery disease. ( Braun, S; Cassese, S; Fusaro, M; Haase, HU; Hadamitzky, M; Kastrati, A; King, L; Ndrepepa, G; Schömig, A; Tada, T, 2013) |
| "Our study showed that uric acid is not associated with platelet aggregation, the extent of coronary artery disease and IMT." | 3.78 | Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. ( Bellomo, G; Cassetti, E; Coppo, L; De Luca, G; Di Mario, C; Iorio, S; Marino, P; Santagostino, M; Secco, GG; Venegoni, L; Verdoia, M, 2012) |
| "Serum uric acid (SUA) is a potential risk factor for atherosclerosis." | 3.78 | Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. ( Bian, L; Choi, Y; Zhang, Z, 2012) |
| "The objective of this study was to explore the relationships between circulating uric acid and lipid levels and components of the metabolic syndrome (MetS) in Arab dyslipidemic patients, a group already at high coronary artery disease risk." | 3.78 | Determinants of blood uric acid levels in a dyslipidemic Arab population. ( Akanji, AO; Al-Meshaweh, AF; Asem, M; Jafar, Y, 2012) |
| "We aimed to elucidate the relation between serum uric acid (SUA) level and severity of coronary artery disease (CAD) in nondiabetic, nonhypertensive patients (n = 246) with acute coronary syndrome (ACS)." | 3.78 | High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. ( Akpek, M; Duran, M; Elcik, D; Ergin, A; Eryol, NK; Inanc, MT; Kalay, N; Kasapkara, HA; Kaya, MG; Ocak, A; Oguzhan, A; Orscelik, O, 2012) |
| "These were post hoc analyses of datasets from the Aspirin Myocardial Infarction Study, a 1:1 randomized, double-blind clinical trial, conducted from 1975 to 1979, that examined mortality rates following daily aspirin administration over three years in individuals with documented MI." | 3.78 | Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. ( Dabbous, O; Hariri, A; Krishnan, E; Lingala, B; Pandya, BJ, 2012) |
| "To examine the association between renal function, serum uric acid and markers of both pro-inflammatory and prothrombotic state in patients with diabetes mellitus (DM), metabolic syndrome and coronary artery disease." | 3.77 | Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. ( Buraczyńska, MJ; Kondracki, B; Rychta, E; Waciński, P; Wysokiński, A; Zapolski, T, 2011) |
| "High serum uric acid (SUA) has been well demonstrated to be associated with morbidity and mortality in the general population as well as in patients with coronary artery disease (CAD)." | 3.77 | Predictors of clinical SYNTAX score in coronary artery disease: serum uric acid, smoking, and Framingham risk stratification. ( Chen, L; Qian, X; Wu, Z; Xiong, Z; Zhu, C; Zhu, J, 2011) |
| "Although increased serum uric acid (SUA) concentrations are commonly encountered in patients with risk factors for coronary artery disease (CAD), the clinical value of SUA has not been established." | 3.76 | Clinical value of serum uric Acid in patients with suspected coronary artery disease. ( Kim, EJ; Kim, JW; Kim, SH; Lim, HE; Park, CG; Rha, SW; Seo, HS, 2010) |
| "This study was designed to determine the relationship between serum uric acid level and the presence and severity of coronary artery disease (CAD)." | 3.76 | The association between serum uric acid level and coronary artery disease. ( Aksoy, H; Aytemir, K; Baris Kaya, E; Evranos, B; Kabakci, G; Okutucu, S; Oto, A; Sinan Deveci, O; Tokgozoglu, L; Tulumen, E, 2010) |
| "To discuss the relationship between high sensitive C-reactive protein (hs-CRP), lipoprotein (Lp)(a), blood uric acid (BUA) and severity of coronary artery disease (CHD)." | 3.76 | [Correlation between high sensitive C-reactive protein, lipoprotein(a), blood uric acid and severity of coronary artery disease]. ( Chen, XL; Ding, YP; He, P; Xie, XH, 2010) |
| "Combined assessment of serum uric acid (UA) and C-reactive protein (CRP) compared with single-marker evaluation in patients with coronary artery disease (CAD) was performed." | 3.75 | Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study). ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P; Goldenberg, I, 2009) |
| "Epidemiological studies have shown that increased serum uric acid (SUA) level is associated with coronary artery disease (CAD)." | 3.75 | Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden. ( Boyaci, B; Cemri, M; Cengel, A; Kocaman, SA; Sahinarslan, A; Timurkaynak, T, 2009) |
| "In patients with coronary artery disease (CAD), elevated serum uric acid (SUA) levels may predict worse cardiovascular outcomes." | 3.75 | Serum uric acid for risk stratification of patients with coronary artery disease. ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P; Goldenberg, I; Mandelzweig, L, 2009) |
| "Serum uric acid concentrations are higher in patients with established coronary artery disease than in healthy controls." | 3.74 | The relationship between coronary artery disease and uric acid levels in young patients with acute myocardial infarction. ( Aktoz, M; Altun, A; Buyuklu, M; Tatli, E, 2008) |
| "We examined the associations of serum uric acid (UA) with indices of coronary heart disease (CHD) risk, including the 10-year probability of CHD (10y-CHDr), metabolic syndrome (MS), inflammation (C-reactive protein [CRP] and fibrinogen), and the presence and quantity of coronary artery calcium (CAC)." | 3.74 | Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. ( Bielak, LF; Coutinho, Tde A; Kullo, IJ; Peyser, PA; Sheedy, PF; Turner, ST, 2007) |
| "Epidemiological studies have shown that a high serum uric acid concentration is a risk factor for coronary artery disease (CAD)." | 3.74 | Independent association of high serum uric acid concentration with angiographically defined coronary artery disease. ( Bogavac-Stanojević, N; Jelić-Ivanović, Z; Memon, L; Spasić, S; Spasojević-Kalimanovska, V, 2007) |
| "Gout and increased serum uric acid (SUA) levels are often seen in patients with components of the metabolic syndrome." | 3.74 | Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. ( Algra, A; Hjortnaes, J; Huisman, M; Jacobs, J; Olijhoek, J; van der Graaf, Y; Visseren, F, 2007) |
| "Plasma total homocysteine, uric acid and allantoin levels of 50 patients with coronary artery diseases and 23 healthy controls were determined by HPLC methods." | 3.73 | Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation. ( Imren, E; Ozkan, Y; Simşek, B; Torun, M; Yardim-Akaydin, S, 2006) |
| "It is a matter of controversy as to whether uric acid is an independent predictor of mortality in patients with coronary artery disease (CAD) or whether it represents only an indirect marker of adverse outcome by reflecting the association between uric acid and other cardiovascular risk factors." | 3.71 | Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. ( Bickel, C; Blankenberg, S; Daunhauer, A; Hafner, G; Hofmann, KP; Meyer, J; Rippin, G; Rupprecht, HJ, 2002) |
| "Comparison of the serum uric acid levels of healthy people (n=71) and patients with cardiovascular diseases (CVD) (n=62)." | 3.70 | Serum uric acid levels in cardiovascular diseases. ( Burgaz, S; Simsek, B; Torun, M; Yardim, S, 1998) |
| " Body mass index (BMI), waist/hip ratio (WHR), blood pressure (BP); oral glucose tolerance test (OGTT) with measurement of serum glucose, insulin and C-peptide every 30 min for 2 h, fasting serum cholesterol, triglycerides and uric acid, areas under curve (AUC) of glucose and insulin, insulin/glucose ratio and insulin sensitivity index were calculated." | 3.69 | Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors. ( Almazán, A; Ariza, CR; Frati, AC; Gómez, G, 1997) |
| "In a group of healthy adult males, the correlation of serum triglycerides with cholesterol, uric acid, blood sugar and obesity was not significant." | 3.64 | Correlation of serum lipids with uric acid and blood sugar in normal males. ( Dunn, JP; Moses, C, 1965) |
| "Hyperuricemia was associated with an increased risk of CHD mortality (RR: 1." | 2.53 | Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. ( Guo, L; Jiang, L; Liu, X; Mao, S; Yin, X; Zuo, T, 2016) |
| "Uric Acid (UA) has been related to the development of Cardio-Vascular (CV) events in patients affected by Chronic Coronary Syndromes (CCS)." | 1.62 | Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular diastolic parameter. ( Bossi, I; De Chiara, B; Giannattasio, C; Maloberti, A; Moreo, A; Nava, S; Oliva, F; Oreglia, J; Piccalò, G; Piccaluga, E; Pirola, R; Racioppi, A; Rebora, P; Soriano, F; Tassistro, E; Vallerio, P; Valsecchi, MG, 2021) |
| "Vitamin D deficiency has been shown to be associated with coronary artery disease (CAD)." | 1.56 | The relationship between a combination of vitamin D deficiency and hyperuricemia and the severity of coronary artery disease in myocardial infarction patients. ( Akgül, F; Akgün, T; Çakır, MO; Can, M; Serbest, NG; Somuncu, MU; Tatar, FP; Tekin, A, 2020) |
| "Hyperuricemia is independently associated with cardiovascular disease (CVD) and is considered to be one of the major risk factors for CVD." | 1.56 | Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention. ( Chan, WL; Charng, MJ; Chen, JW; Chen, SC; Chen, YH; Cheng, HM; Chou, CY; Hsu, PF; Huang, CC; Huang, PH; Huang, SS; Leu, HB; Lim, SS; Lin, SJ; Lin, YJ; Lu, TM; Pan, JP; Sung, SH; Wu, CH; Wu, TC; Yang, YL, 2020) |
| "Hyperuricemia is closely associated with cardiovascular disease (CVD)." | 1.56 | Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot. ( Angerås, O; Bergström, G; Dehlin, M; Drivelegka, P; Forsblad-d'Elia, H; Jacobsson, LTH; Schmidt, C, 2020) |
| "Hyperuricemia was shown to be an independent risk factor for CAD severity in young adults with ACS (18-35 years of age)." | 1.51 | Hyperuricemia and severity of coronary artery disease: An observational study in adults 35 years of age and younger with acute coronary syndrome. ( Alhelal, JW; Liu, W; Liu, X; Liu, Y; Lv, S; Ravuru, KSS; Shi, D; Zhao, Y; Zhou, Y, 2019) |
| "In conclusion, hyperuricemia is relatively common among patients with severe CAD and is independently associated with mortality." | 1.51 | Implications of Hyperuricemia in Severe Coronary Artery Disease. ( Feng, X; Gao, R; Hui, R; Jiang, L; Liu, J; Song, L; Sun, K; Tian, J; Wang, D; Xu, B; Xu, L; Yuan, J; Zhang, C; Zhang, Y; Zhao, W; Zhao, X, 2019) |
| "People with gout are at an increased risk of readmission for heart failure and have longer hospital stays." | 1.51 | Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study. ( Doughty, RN; Drake, J; Frampton, C; Richards, AM; Stamp, LK; Troughton, RW, 2019) |
| "Coronary atherosclerotic plaques (calcified, mixed, and non-calcified plaques) were assessed using CCTA." | 1.51 | Serum uric acid level and subclinical coronary atherosclerosis in asymptomatic individuals: An observational cohort study. ( Choe, J; Choi, SW; Hong, S; Kang, JW; Kim, HK; Kim, YG; Kim, YH; Lee, CK; Lee, SW; Lee, Y; Lim, DH; Lim, TH; Park, GM; Yang, DH; Yoo, B, 2019) |
| "Hyperuricemia was frequently noted in subjects with a high risk of cardiovascular disease (CVD)." | 1.48 | Elevated serum uric acid predicts the development of moderate coronary artery calcification independent of conventional cardiovascular risk factors. ( Ahn, JY; Hur, KY; Jin, SM; Jun, JE; Kang, MR; Kim, G; Kim, JH; Lee, MK; Lee, SE; Lee, YB, 2018) |
| "Hyperuricemia is not associated with poor clinical outcomes after repeat PCI for ISR lesions." | 1.48 | Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis. ( Hong, SJ; Jeong, HS; Joo, HJ; Kook, H; Lee, SH; Lim, DS; Park, JH; Yu, CW, 2018) |
| "These findings suggested that higher SUA levels were independently associated with a dose-response increased risk of CHD incidence." | 1.43 | Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji Cohort. ( Angileri, F; Chen, X; Fang, Q; He, MA; Lai, X; Légaré, S; Li, X; Min, X; Wu, T; Xu, C; Yang, H; Yang, L; Yuan, J; Zhang, C; Zhang, X, 2016) |
| "The total burden of subclinical coronary atherosclerosis is significant in young adults." | 1.42 | Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults. ( Akin, F; Akturk, F; Ayca, B; Birand, A; Celik, O; Erturk, M; Kaya, MG; Ozturk, D; Pusuroglu, H; Satilmis, S; Yalcin, AA, 2015) |
| "Serum UA (r=0." | 1.40 | Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy. ( Fukui, K; Hibi, K; Kunishima, T; Michishita, I; Nozue, T; Onishi, Y; Terashima, M; Tohyama, S; Umezawa, S; Yamamoto, S, 2014) |
| "Uric acid did not seem to be an independent risk factor for coronary artery calcium, although the prevalence and extent of coronary artery calcium increased along with the increasing trend of uric acid." | 1.39 | [Relation between uric acid and coronary artery calcification:a community-based cross-sectional survey among Beijing natural population]. ( Cao, HL; Chen, XB; Chen, Y; Gao, Y; Gu, DF; Hou, ZH; Jiang, SL; Li, Y; Lu, JG; LV, B; Tang, X; Yu, FF; Zhao, LC, 2013) |
| "In conclusion, in patients with Type 2 diabetes mellitus and confirmed CAD, elevated levels of UA predict mortality independently of known cardiovascular risk factors." | 1.39 | Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. ( Braun, S; Cassese, S; Fusaro, M; Haase, HU; Hadamitzky, M; Kastrati, A; King, L; Ndrepepa, G; Schömig, A; Tada, T, 2013) |
| "Endothelial dysfunction characterized by decreased nitric oxide (NO) bioavailability is the first stage of coronary artery disease." | 1.39 | Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. ( Baldus, S; Klinke, A; Kolářová, H; Kubala, L; Lau, D; Lojek, A; Papežíková, I; Pekarová, M, 2013) |
| "Uric acid was measured before angiography." | 1.38 | Association of uric acid with mortality in patients with stable coronary artery disease. ( Birkmeier, KA; Braun, S; Haase, HU; Hadamitzky, M; Kastrati, A; King, L; Ndrepepa, G; Schömig, A, 2012) |
| "Uric acid was higher in subjects without diabetes than in those with diabetes (P = 0." | 1.37 | Uric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes. ( da Silva, PB; de Fátima Bevilácqua da Matta, M; Gomes, MB; Matheus, AS; Tibiriçá, E, 2011) |
| "Insulin resistance was assessed by a 75-g oral glucose tolerance test and homeostasis model assessment (HOMA)." | 1.30 | Insulin resistance and angiographical characteristics of coronary atherosclerosis. ( Arakawa, K; Saku, K; Shirai, K; Takezako, T; Zhang, B, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (3.33) | 18.7374 |
| 1990's | 10 (4.76) | 18.2507 |
| 2000's | 27 (12.86) | 29.6817 |
| 2010's | 127 (60.48) | 24.3611 |
| 2020's | 39 (18.57) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, I | 1 |
| Moriya, S | 1 |
| Kurozumi, M | 1 |
| Namba, T | 1 |
| Takagi, Y | 1 |
| Xu, S | 1 |
| Liu, L | 1 |
| Yin, G | 1 |
| Mohammed, AQ | 1 |
| Lv, X | 1 |
| Feng, C | 1 |
| Shi, T | 1 |
| Abdu, FA | 1 |
| Che, W | 1 |
| Zhang, S | 1 |
| Liu, X | 4 |
| Song, B | 1 |
| Yu, H | 1 |
| Zhang, X | 5 |
| Shao, Y | 1 |
| Mantovani, A | 1 |
| Bonapace, S | 1 |
| Dugo, C | 1 |
| Beatrice, G | 1 |
| Petracca, G | 1 |
| Cappelli, D | 1 |
| Csermely, A | 1 |
| Molon, G | 1 |
| Targher, G | 1 |
| Zhang, Y | 6 |
| Jiang, W | 1 |
| Mangalesh, S | 1 |
| Yadav, P | 1 |
| Dudani, S | 1 |
| Mahesh, NK | 1 |
| Chu, X | 1 |
| Lu, Y | 2 |
| Mei, M | 1 |
| Peng, P | 1 |
| Zhao, Y | 3 |
| Fu, G | 2 |
| Qiu, F | 1 |
| Jin, C | 1 |
| Mackenzie, IS | 1 |
| Hawkey, CJ | 1 |
| Ford, I | 1 |
| Greenlaw, N | 1 |
| Pigazzani, F | 1 |
| Rogers, A | 1 |
| Struthers, AD | 1 |
| Begg, AG | 1 |
| Wei, L | 2 |
| Avery, AJ | 1 |
| Taggar, JS | 1 |
| Walker, A | 1 |
| Duce, SL | 1 |
| Barr, RJ | 1 |
| Dumbleton, JS | 1 |
| Rooke, ED | 1 |
| Townend, JN | 1 |
| Ritchie, LD | 1 |
| MacDonald, TM | 1 |
| Hiraga, T | 1 |
| Saito, Y | 1 |
| Tateishi, K | 1 |
| Mori, N | 1 |
| Murase, T | 3 |
| Nakamura, T | 3 |
| Akari, S | 1 |
| Saito, K | 1 |
| Kitahara, H | 1 |
| Kobayashi, Y | 1 |
| Khameneh Bagheri, R | 3 |
| Najafi, MN | 3 |
| Ahmadi, M | 3 |
| Saberi, M | 3 |
| Maleki, M | 3 |
| Baradaran Rahimi, V | 3 |
| Nahar, K | 1 |
| Hasan, MZ | 1 |
| Tuli, JZ | 1 |
| Hoque, MR | 1 |
| Akhter, S | 1 |
| Runa, US | 1 |
| Li, HY | 1 |
| Ji, HY | 1 |
| Maimaitituersun, G | 1 |
| Ma, YT | 1 |
| Fu, ZY | 1 |
| Shimizu, M | 2 |
| Kasai, T | 2 |
| Naito, R | 2 |
| Sato, A | 2 |
| Ishiwata, S | 2 |
| Yatsu, S | 2 |
| Shitara, J | 2 |
| Matsumoto, H | 2 |
| Murata, A | 2 |
| Kato, T | 2 |
| Suda, S | 2 |
| Hiki, M | 2 |
| Kuwabara, M | 3 |
| Daida, H | 1 |
| Cimmino, G | 1 |
| Gallinoro, E | 1 |
| di Serafino, L | 1 |
| De Rosa, G | 1 |
| Sugraliyev, A | 1 |
| Golino, P | 1 |
| Cirillo, P | 1 |
| Mikagi, M | 1 |
| Tashiro, K | 1 |
| Komaki, T | 1 |
| Shiga, Y | 1 |
| Tachibana, T | 1 |
| Higashi, S | 1 |
| Kawahira, Y | 1 |
| Suematsu, Y | 1 |
| Ideishi, A | 1 |
| Ogawa, M | 1 |
| Miura, SI | 1 |
| Ando, SI | 1 |
| Cui, K | 1 |
| Song, Y | 3 |
| Yin, D | 1 |
| Song, W | 1 |
| Wang, H | 4 |
| Zhu, C | 2 |
| Feng, L | 1 |
| Fu, R | 1 |
| Jia, L | 1 |
| Zhang, D | 1 |
| Song, C | 1 |
| Yang, Y | 3 |
| Dong, Q | 2 |
| Dou, K | 1 |
| Liu, W | 3 |
| Ding, K | 1 |
| Bao, J | 1 |
| Hu, Y | 1 |
| Gui, Y | 1 |
| Ye, L | 1 |
| Wang, L | 1 |
| Yang, B | 1 |
| Ma, K | 1 |
| Xiang, R | 1 |
| Yang, G | 1 |
| Luo, Y | 1 |
| Wu, F | 1 |
| Mao, M | 1 |
| Olsen, T | 1 |
| Vinknes, KJ | 1 |
| Blomhoff, R | 1 |
| Lysne, V | 1 |
| Midttun, Ø | 1 |
| Dhar, I | 1 |
| Ueland, PM | 1 |
| Svingen, GFT | 1 |
| Pedersen, EKR | 1 |
| Drevon, CA | 1 |
| Refsum, H | 1 |
| Nygård, OK | 1 |
| Liang, L | 1 |
| Hou, X | 2 |
| Bainey, KR | 1 |
| Tymchak, W | 1 |
| Qi, Z | 1 |
| Li, W | 1 |
| Banh, HL | 1 |
| Somuncu, MU | 1 |
| Serbest, NG | 1 |
| Akgül, F | 1 |
| Çakır, MO | 1 |
| Akgün, T | 1 |
| Tatar, FP | 1 |
| Can, M | 1 |
| Tekin, A | 1 |
| H, C | 1 |
| Ac, N | 1 |
| Lim, SS | 1 |
| Yang, YL | 1 |
| Chen, SC | 1 |
| Wu, CH | 1 |
| Huang, SS | 1 |
| Chan, WL | 1 |
| Lin, SJ | 1 |
| Chen, JW | 1 |
| Chou, CY | 1 |
| Pan, JP | 1 |
| Charng, MJ | 1 |
| Chen, YH | 1 |
| Wu, TC | 1 |
| Lu, TM | 1 |
| Hsu, PF | 1 |
| Huang, PH | 1 |
| Cheng, HM | 1 |
| Huang, CC | 1 |
| Sung, SH | 1 |
| Lin, YJ | 1 |
| Leu, HB | 1 |
| Drivelegka, P | 1 |
| Forsblad-d'Elia, H | 1 |
| Angerås, O | 1 |
| Bergström, G | 1 |
| Schmidt, C | 1 |
| Jacobsson, LTH | 1 |
| Dehlin, M | 1 |
| Guo, G | 1 |
| Huang, Z | 1 |
| Wang, S | 1 |
| Chen, X | 2 |
| Xu, JJ | 1 |
| Jiang, L | 3 |
| Yao, Y | 1 |
| Jia, SD | 1 |
| Liu, Y | 4 |
| Yuan, DS | 1 |
| Li, TY | 1 |
| Chen, J | 1 |
| Wu, Y | 1 |
| Zhang, J | 2 |
| Chen, JL | 1 |
| Yang, YJ | 1 |
| Gao, RL | 1 |
| Qiao, SB | 1 |
| Xu, B | 2 |
| Yuan, JQ | 1 |
| Wang, J | 1 |
| Abdus, S | 1 |
| Tan, C | 1 |
| Gu, Q | 1 |
| Yang, M | 1 |
| Wang, G | 1 |
| Shi, L | 2 |
| Gong, X | 1 |
| Li, C | 2 |
| Shi, Y | 1 |
| Du, J | 1 |
| Chen, S | 2 |
| Zhang, H | 2 |
| Yang, L | 2 |
| Zheng, Z | 1 |
| Nardin, M | 4 |
| Verdoia, M | 6 |
| Negro, F | 1 |
| Tonon, F | 1 |
| De Luca, G | 6 |
| Huang, CP | 1 |
| Chen, WL | 1 |
| Chen, Z | 1 |
| Feng, J | 1 |
| Zhou, G | 1 |
| Jin, X | 1 |
| Pan, J | 1 |
| Mozzini, C | 1 |
| Girelli, D | 1 |
| Setti, A | 1 |
| Croce, J | 1 |
| Stefanoni, F | 1 |
| Castagna, A | 1 |
| Pizzolo, F | 1 |
| Friso, S | 1 |
| Olivieri, O | 1 |
| Martinelli, N | 1 |
| Yang, Z | 1 |
| Yuan, J | 4 |
| Cui, J | 1 |
| Guan, H | 1 |
| Qiao, S | 1 |
| Maloberti, A | 1 |
| Bossi, I | 1 |
| Tassistro, E | 1 |
| Rebora, P | 1 |
| Racioppi, A | 1 |
| Nava, S | 1 |
| Soriano, F | 1 |
| Piccaluga, E | 1 |
| Piccalò, G | 1 |
| Oreglia, J | 1 |
| Vallerio, P | 1 |
| Pirola, R | 1 |
| De Chiara, B | 1 |
| Oliva, F | 1 |
| Moreo, A | 1 |
| Valsecchi, MG | 1 |
| Giannattasio, C | 1 |
| Mahdavi-Roshan, M | 1 |
| Salari, A | 1 |
| Ghorbani, Z | 1 |
| Nikpey, Z | 1 |
| Haghighatkhah, M | 1 |
| Fakhr Mousavi, A | 1 |
| Gholipour, M | 1 |
| Pourfarzad, A | 1 |
| Demiray, A | 1 |
| Afsar, B | 1 |
| Covic, A | 3 |
| Ferro, CJ | 1 |
| Lanaspa, MA | 1 |
| Johnson, RJ | 6 |
| Kanbay, M | 4 |
| Jin, Z | 1 |
| Zhao, Q | 1 |
| Yang, F | 1 |
| Xu, T | 1 |
| Wang, Y | 3 |
| Zhang, K | 1 |
| Zhang, W | 1 |
| Kim, H | 1 |
| Kim, SH | 2 |
| Choi, AR | 1 |
| Kim, S | 1 |
| Choi, HY | 1 |
| Kim, HJ | 1 |
| Park, HC | 1 |
| Ciccarelli, G | 1 |
| Mangiacapra, F | 1 |
| Pellicano, M | 1 |
| Barbato, E | 1 |
| Zhang, JW | 2 |
| Liu, WW | 1 |
| McCaffrey, TA | 1 |
| He, XQ | 1 |
| Liang, WY | 1 |
| Chen, XH | 1 |
| Feng, XR | 1 |
| Fu, SW | 1 |
| Liu, ML | 1 |
| Lazzeroni, D | 1 |
| Bini, M | 1 |
| Camaiora, U | 1 |
| Castiglioni, P | 1 |
| Moderato, L | 1 |
| Bosi, D | 1 |
| Geroldi, S | 1 |
| Ugolotti, PT | 1 |
| Brambilla, L | 1 |
| Brambilla, V | 1 |
| Coruzzi, P | 1 |
| Larsen, TR | 1 |
| Gerke, O | 1 |
| Diederichsen, ACP | 1 |
| Lambrechtsen, J | 1 |
| Steffensen, FH | 1 |
| Sand, NP | 1 |
| Saaby, L | 1 |
| Antonsen, S | 1 |
| Mickley, H | 1 |
| Dierkes, J | 1 |
| Seifert, R | 1 |
| Gregory, JF | 1 |
| Nygård, O | 1 |
| Qin, X | 1 |
| Li, Y | 2 |
| Hou, FF | 1 |
| Jun, JE | 1 |
| Lee, YB | 1 |
| Lee, SE | 1 |
| Ahn, JY | 1 |
| Kim, G | 1 |
| Jin, SM | 1 |
| Hur, KY | 1 |
| Lee, MK | 1 |
| Kang, MR | 1 |
| Kim, JH | 1 |
| Andrikou, I | 1 |
| Tsioufis, C | 1 |
| Dimitriadis, K | 1 |
| Konstantinidis, D | 1 |
| Kasiakogias, A | 1 |
| Kouremeti, M | 1 |
| Andrikou, E | 1 |
| Karapati, I | 1 |
| Kalos, T | 1 |
| Fragoulis, C | 1 |
| Liatakis, I | 1 |
| Koutra, E | 1 |
| Kyriazopoulos, K | 1 |
| Thomopoulos, C | 1 |
| Tousoulis, D | 1 |
| Lv, S | 3 |
| Zhou, Y | 3 |
| Shi, D | 2 |
| Alhelal, JW | 1 |
| Ravuru, KSS | 1 |
| Gaubert, M | 1 |
| Marlinge, M | 1 |
| Alessandrini, M | 1 |
| Laine, M | 1 |
| Bonello, L | 1 |
| Fromonot, J | 2 |
| Cautela, J | 1 |
| Thuny, F | 1 |
| Barraud, J | 1 |
| Mottola, G | 2 |
| Rossi, P | 1 |
| Fenouillet, E | 2 |
| Ruf, J | 2 |
| Guieu, R | 2 |
| Paganelli, F | 1 |
| Ndrepepa, G | 5 |
| Tasić, I | 1 |
| Kostić, S | 1 |
| Stojanović, NM | 1 |
| Skakić, V | 1 |
| Cvetković, J | 1 |
| Djordjević, A | 1 |
| Karadzić, M | 1 |
| Djordjević, D | 1 |
| Andonov, S | 1 |
| Stoičkov, V | 1 |
| Tasić, D | 1 |
| Vanka, M | 1 |
| Lović, D | 1 |
| Joo, HJ | 1 |
| Jeong, HS | 1 |
| Kook, H | 1 |
| Lee, SH | 2 |
| Park, JH | 1 |
| Hong, SJ | 1 |
| Yu, CW | 1 |
| Lim, DS | 1 |
| Karabağ, Y | 1 |
| Rencuzogullari, I | 1 |
| Çağdaş, M | 1 |
| Karakoyun, S | 1 |
| Yesin, M | 1 |
| Atalay, E | 1 |
| Çağdaş, ÖS | 1 |
| Gürsoy, MO | 1 |
| Burak, C | 1 |
| Tanboğa, HI | 1 |
| Macias-Kauffer, LR | 1 |
| Villamil-Ramírez, H | 1 |
| León-Mimila, P | 1 |
| Jacobo-Albavera, L | 1 |
| Posadas-Romero, C | 1 |
| Posadas-Sánchez, R | 1 |
| López-Contreras, BE | 1 |
| Morán-Ramos, S | 1 |
| Romero-Hidalgo, S | 1 |
| Acuña-Alonzo, V | 1 |
| Del-Río-Navarro, BE | 1 |
| Bortolini, MC | 1 |
| Gallo, C | 1 |
| Bedoya, G | 1 |
| Rothhammer, F | 1 |
| González-Jose, R | 1 |
| Ruiz-Linares, A | 1 |
| Stephens, CR | 1 |
| Velazquez-Cruz, R | 1 |
| Fernández Del Valle-Laisequilla, C | 1 |
| Reyes-García, JG | 1 |
| Barranco Garduño, LM | 1 |
| Carrasco-Portugal, MDC | 1 |
| Flores-Murrieta, FJ | 1 |
| Vargas-Alarcón, G | 1 |
| Aguilar-Salinas, CA | 1 |
| Villarreal-Molina, T | 1 |
| Canizales-Quinteros, S | 1 |
| Lan, M | 1 |
| Liu, B | 2 |
| He, Q | 1 |
| Kiss, LZ | 1 |
| Bagyura, Z | 1 |
| Csobay-Novák, C | 1 |
| Lux, Á | 1 |
| Polgár, L | 1 |
| Jermendy, Á | 1 |
| Soós, P | 1 |
| Szelid, Z | 1 |
| Maurovich-Horvat, P | 1 |
| Becker, D | 1 |
| Merkely, B | 1 |
| Tian, TT | 1 |
| Li, H | 2 |
| Chen, SJ | 1 |
| Wang, Q | 1 |
| Tian, QW | 1 |
| Zhang, BB | 1 |
| Zhu, J | 3 |
| He, GW | 1 |
| Lun, LM | 1 |
| Xuan, C | 1 |
| Zhang, C | 2 |
| Xu, L | 1 |
| Tian, J | 1 |
| Liu, J | 1 |
| Zhao, X | 1 |
| Feng, X | 1 |
| Wang, D | 1 |
| Sun, K | 1 |
| Zhao, W | 1 |
| Hui, R | 1 |
| Gao, R | 1 |
| Song, L | 1 |
| Harada, PH | 1 |
| Benseñor, IM | 1 |
| Bittencourt, MS | 1 |
| Nasir, K | 3 |
| Blaha, MJ | 1 |
| Jones, SR | 1 |
| Toth, PP | 1 |
| Lotufo, PA | 1 |
| Sun, Y | 2 |
| Tian, W | 1 |
| Chen, L | 3 |
| Li, J | 1 |
| Zhao, S | 1 |
| Qi, G | 2 |
| Ohene, BE | 1 |
| Stamp, LK | 1 |
| Frampton, C | 1 |
| Drake, J | 1 |
| Doughty, RN | 1 |
| Troughton, RW | 1 |
| Richards, AM | 1 |
| Xing, Y | 1 |
| Guo, JT | 1 |
| Gai, LY | 1 |
| Luo, DL | 1 |
| Kumbhalkar, S | 1 |
| Deotale, R | 1 |
| Lim, DH | 1 |
| Lee, Y | 1 |
| Park, GM | 1 |
| Choi, SW | 1 |
| Kim, YG | 2 |
| Lee, SW | 2 |
| Kim, YH | 1 |
| Yang, DH | 1 |
| Kang, JW | 1 |
| Lim, TH | 1 |
| Kim, HK | 1 |
| Choe, J | 1 |
| Hong, S | 1 |
| Lee, CK | 1 |
| Yoo, B | 1 |
| Li, YH | 3 |
| Lin, GM | 3 |
| Lin, CL | 2 |
| Wang, JH | 2 |
| Chen, YJ | 1 |
| Han, CL | 2 |
| Yalcin, M | 1 |
| Kardesoglu, E | 1 |
| Isilak, Z | 1 |
| Uz, O | 1 |
| Atalay, M | 1 |
| Tezcan, M | 1 |
| Uzun, M | 1 |
| Sitki Cebeci, B | 1 |
| Jacobs, DR | 3 |
| Gaffo, AL | 3 |
| Gross, MD | 2 |
| Goff, DC | 2 |
| Carr, JJ | 2 |
| Uysal, OK | 3 |
| Sahin, DY | 3 |
| Duran, M | 4 |
| Turkoglu, C | 1 |
| Yildirim, A | 1 |
| Elbasan, Z | 2 |
| Ozkan, B | 2 |
| Tekin, K | 2 |
| Kunak, AU | 1 |
| Yilmaz, Y | 2 |
| Kaya, MG | 6 |
| Gur, M | 3 |
| Cayli, M | 3 |
| Cassese, S | 3 |
| Braun, S | 4 |
| Fusaro, M | 3 |
| King, L | 4 |
| Tada, T | 3 |
| Schömig, A | 4 |
| Kastrati, A | 4 |
| Schmidt, R | 1 |
| Cao, HL | 1 |
| LV, B | 1 |
| Chen, XB | 1 |
| Lu, JG | 1 |
| Hou, ZH | 1 |
| Tang, X | 1 |
| Gao, Y | 1 |
| Yu, FF | 1 |
| Chen, Y | 3 |
| Jiang, SL | 1 |
| Zhao, LC | 1 |
| Gu, DF | 1 |
| Sarlı, B | 1 |
| Baktır, AO | 1 |
| Sağlam, H | 1 |
| Arınç, H | 1 |
| Kurtul, S | 1 |
| Karadağ, Z | 1 |
| Katlandur, H | 1 |
| Akpek, M | 2 |
| Canpolat, U | 2 |
| Cagli, K | 1 |
| Aras, D | 1 |
| Kisacik, HL | 1 |
| Aydogdu, S | 1 |
| Koza, Y | 1 |
| Lazoglu, Z | 1 |
| Aksakal, E | 1 |
| Ates, ES | 1 |
| Solak, Y | 2 |
| Akilli, H | 1 |
| Kayrak, M | 1 |
| Aribas, A | 1 |
| Gaipov, A | 1 |
| Turk, S | 1 |
| Perez-Pozo, SE | 1 |
| McFann, K | 1 |
| Nozue, T | 1 |
| Yamamoto, S | 1 |
| Tohyama, S | 1 |
| Fukui, K | 1 |
| Umezawa, S | 1 |
| Onishi, Y | 1 |
| Kunishima, T | 1 |
| Hibi, K | 1 |
| Terashima, M | 1 |
| Michishita, I | 1 |
| Knowles, JW | 1 |
| Reaven, G | 1 |
| Calvo, RY | 1 |
| Araneta, MR | 1 |
| Kritz-Silverstein, D | 1 |
| Laughlin, GA | 1 |
| Barrett-Connor, E | 1 |
| Akin, F | 2 |
| Celik, O | 2 |
| Ayça, B | 2 |
| Yalçin, AA | 2 |
| Altun, I | 1 |
| Köse, N | 1 |
| Barbieri, L | 4 |
| Schaffer, A | 3 |
| Cassetti, E | 2 |
| Bellomo, G | 4 |
| Aimaretti, G | 1 |
| Marino, P | 5 |
| Sinigaglia, F | 1 |
| Yu, J | 1 |
| Han, J | 1 |
| Mao, J | 1 |
| Guo, L | 2 |
| Gao, W | 1 |
| Bjornstad, P | 1 |
| Maahs, DM | 2 |
| Rivard, CJ | 1 |
| Pyle, L | 1 |
| Rewers, M | 2 |
| Snell-Bergeon, JK | 2 |
| Dursun, S | 1 |
| Çuhadar, S | 1 |
| Köseoğlu, M | 1 |
| Atay, A | 1 |
| Aktaş, SG | 1 |
| Pafili, K | 1 |
| Katsiki, N | 1 |
| Mikhailidis, DP | 1 |
| Papanas, N | 1 |
| Yu, X | 1 |
| Zhi, Y | 1 |
| Geng, S | 1 |
| Liu, T | 1 |
| Xu, K | 1 |
| Wu, C | 1 |
| Gawron-Skarbek, A | 1 |
| Chrzczanowicz, J | 1 |
| Kostka, J | 1 |
| Nowak, D | 1 |
| Drygas, W | 1 |
| Jegier, A | 1 |
| Kostka, T | 1 |
| He, LJ | 1 |
| Cao, SJ | 1 |
| Yang, Q | 1 |
| Yang, SW | 1 |
| Zhou, YJ | 1 |
| Li, F | 1 |
| Xia, K | 1 |
| Yang, T | 1 |
| Demir, Ş | 1 |
| Karakoyun, G | 1 |
| Kanadasi, M | 1 |
| Dunn, JP | 1 |
| Moses, C | 1 |
| Tanındı, A | 1 |
| Erkan, AF | 1 |
| Alhan, A | 2 |
| Töre, HF | 2 |
| Xu, RX | 1 |
| Li, S | 2 |
| Zhu, CG | 1 |
| Guo, YL | 1 |
| Sun, J | 1 |
| Li, JJ | 1 |
| Dai, XM | 1 |
| Ma, LL | 1 |
| Chen, HY | 1 |
| Zhang, ZJ | 1 |
| Ji, ZF | 1 |
| Wu, WL | 1 |
| Ma, LY | 1 |
| Kong, XF | 1 |
| Jiang, LD | 1 |
| Ozturk, D | 1 |
| Satilmis, S | 1 |
| Erturk, M | 1 |
| Akturk, F | 1 |
| Birand, A | 1 |
| Pusuroglu, H | 1 |
| Ekici, B | 1 |
| Kütük, U | 1 |
| Sertoglu, E | 1 |
| Suryapranata, H | 3 |
| Meng, J | 1 |
| Tan, W | 1 |
| Zhu, Y | 1 |
| Wang, F | 1 |
| Li, X | 3 |
| Zhang, M | 1 |
| Malik, R | 1 |
| Aneni, EC | 1 |
| Shahrayar, S | 1 |
| Freitas, WM | 1 |
| Ali, SS | 1 |
| Veledar, E | 1 |
| Latif, MA | 1 |
| Aziz, M | 1 |
| Ahmed, R | 1 |
| Khan, SA | 1 |
| Joseph, J | 1 |
| Feiz, H | 1 |
| Sposito, A | 1 |
| Niu, S | 1 |
| Hu, W | 1 |
| Bando, S | 1 |
| Fukuda, D | 1 |
| Soeki, T | 1 |
| Nishimoto, S | 1 |
| Uematsu, E | 1 |
| Matsuura, T | 1 |
| Ise, T | 1 |
| Tobiume, T | 1 |
| Yamaguchi, K | 1 |
| Yagi, S | 1 |
| Iwase, T | 1 |
| Yamada, H | 1 |
| Wakatsuki, T | 1 |
| Shimabukuro, M | 1 |
| Sata, M | 1 |
| Biscaglia, S | 1 |
| Ceconi, C | 1 |
| Malagù, M | 1 |
| Pavasini, R | 1 |
| Ferrari, R | 1 |
| Song, X | 1 |
| Che, K | 1 |
| Wang, R | 2 |
| Sun, W | 1 |
| Huang, ZC | 1 |
| Lu, TS | 1 |
| You, SJ | 1 |
| Cao, YJ | 1 |
| Liu, CF | 1 |
| Yildiz, BS | 1 |
| Ozkan, E | 1 |
| Esin, F | 1 |
| Alihanoglu, YI | 1 |
| Ozkan, H | 1 |
| Bilgin, M | 1 |
| Kilic, ID | 1 |
| Ergin, A | 2 |
| Kaftan, HA | 1 |
| Evrengul, H | 1 |
| Ejaz, AA | 1 |
| Alquadan, KF | 1 |
| Dass, B | 1 |
| Shimada, M | 1 |
| Andrés, M | 1 |
| Quintanilla, MA | 1 |
| Sivera, F | 1 |
| Sánchez-Payá, J | 1 |
| Pascual, E | 1 |
| Vela, P | 1 |
| Ruiz-Nodar, JM | 1 |
| Deharo, P | 1 |
| Bruzzese, L | 1 |
| Cuisset, T | 1 |
| Quilici, J | 1 |
| Bonatti, S | 1 |
| Pergolini, P | 2 |
| Rolla, R | 2 |
| Ando, K | 1 |
| Takahashi, H | 1 |
| Watanabe, T | 1 |
| Daidoji, H | 1 |
| Otaki, Y | 1 |
| Nishiyama, S | 1 |
| Arimoto, T | 1 |
| Shishido, T | 1 |
| Miyashita, T | 1 |
| Miyamoto, T | 1 |
| Kubota, I | 1 |
| Li, Q | 1 |
| Ding, D | 1 |
| Chen, Q | 1 |
| Liu, C | 1 |
| Hong, C | 1 |
| Ling, W | 1 |
| von Lueder, TG | 1 |
| Girerd, N | 1 |
| Salavati, A | 1 |
| Mehrsai, A | 1 |
| Allameh, F | 1 |
| Alizadeh, F | 1 |
| Namdari, F | 1 |
| Hosseinian, M | 1 |
| Salimi, E | 1 |
| Heidari, F | 1 |
| Pourmand, G | 1 |
| Sakakibara, M | 1 |
| Tsutsui, H | 1 |
| Jamshed, H | 1 |
| Gilani, AU | 1 |
| Sultan, FA | 1 |
| Amin, F | 1 |
| Arslan, J | 1 |
| Ghani, S | 1 |
| Masroor, M | 1 |
| Lai, X | 1 |
| Légaré, S | 1 |
| Angileri, F | 1 |
| Fang, Q | 1 |
| Yang, H | 1 |
| Min, X | 1 |
| Xu, C | 1 |
| He, MA | 1 |
| Wu, T | 1 |
| Yan, Y | 1 |
| Ding, Z | 1 |
| Zuo, T | 1 |
| Mao, S | 1 |
| Yin, X | 1 |
| Prasad, M | 1 |
| Matteson, EL | 1 |
| Herrmann, J | 1 |
| Gulati, R | 1 |
| Rihal, CS | 2 |
| Lerman, LO | 2 |
| Lerman, A | 3 |
| Tsai, IT | 1 |
| Wang, CP | 1 |
| Lu, YC | 1 |
| Hung, WC | 1 |
| Wu, CC | 1 |
| Lu, LF | 1 |
| Chung, FM | 1 |
| Hsu, CC | 1 |
| Lee, YJ | 1 |
| Yu, TH | 1 |
| Fazlioğlu, M | 1 |
| Sentürk, T | 1 |
| Kumbay, E | 1 |
| Kaderli, AA | 1 |
| Ozdemir, B | 1 |
| Baran, I | 1 |
| Aydinlar, A | 1 |
| Gagliardi, AC | 1 |
| Miname, MH | 1 |
| Santos, RD | 2 |
| Tatli, E | 1 |
| Aktoz, M | 1 |
| Buyuklu, M | 1 |
| Altun, A | 1 |
| Sixt, S | 1 |
| Rastan, A | 1 |
| Desch, S | 1 |
| Sonnabend, M | 1 |
| Schmidt, A | 1 |
| Schuler, G | 1 |
| Niebauer, J | 1 |
| Tanaka, M | 1 |
| Tomiyasu, K | 1 |
| Fukui, M | 1 |
| Akabame, S | 1 |
| Kobayashi-Takenaka, Y | 1 |
| Nakano, K | 1 |
| Kadono, M | 1 |
| Hasegawa, G | 1 |
| Oda, Y | 1 |
| Nakamura, N | 1 |
| Dunkelgrun, M | 1 |
| Welten, GM | 1 |
| Goei, D | 1 |
| Winkel, TA | 1 |
| Schouten, O | 1 |
| van Domburg, RT | 1 |
| van Gestel, YR | 1 |
| Flu, WJ | 1 |
| Hoeks, SE | 1 |
| Bax, JJ | 1 |
| Poldermans, D | 1 |
| Nunes, JP | 1 |
| Silva, JC | 1 |
| Brodov, Y | 3 |
| Behar, S | 3 |
| Goldenberg, I | 2 |
| Boyko, V | 3 |
| Chouraqui, P | 3 |
| Strait, JB | 1 |
| Uda, M | 1 |
| Lakatta, EG | 1 |
| Najjar, SS | 1 |
| Kocaman, SA | 1 |
| Sahinarslan, A | 1 |
| Cemri, M | 1 |
| Timurkaynak, T | 1 |
| Boyaci, B | 1 |
| Cengel, A | 1 |
| Mandelzweig, L | 1 |
| Stark, K | 2 |
| Reinhard, W | 2 |
| Grassl, M | 1 |
| Erdmann, J | 2 |
| Schunkert, H | 2 |
| Illig, T | 1 |
| Hengstenberg, C | 2 |
| Lim, HE | 1 |
| Kim, EJ | 1 |
| Kim, JW | 1 |
| Rha, SW | 1 |
| Seo, HS | 1 |
| Park, CG | 1 |
| Sinan Deveci, O | 1 |
| Kabakci, G | 2 |
| Okutucu, S | 1 |
| Tulumen, E | 1 |
| Aksoy, H | 1 |
| Baris Kaya, E | 1 |
| Evranos, B | 1 |
| Aytemir, K | 2 |
| Tokgozoglu, L | 2 |
| Oto, A | 2 |
| Spoon, DB | 1 |
| Rule, AD | 1 |
| Prasad, A | 2 |
| Lennon, RJ | 1 |
| Holmes, DR | 1 |
| Reriani, M | 1 |
| Raichlin, E | 1 |
| Mathew, V | 1 |
| Pumper, GM | 1 |
| Nelson, RE | 1 |
| Lennon, R | 1 |
| Rihal, C | 1 |
| Rodrigues, TC | 1 |
| Jalal, DI | 1 |
| Kinney, GL | 1 |
| Rivard, C | 1 |
| Kaya, EB | 1 |
| Yorgun, H | 1 |
| Hazırolan, T | 1 |
| Sunman, H | 1 |
| Ülgen, A | 1 |
| Ates, AH | 1 |
| Akata, D | 1 |
| Neogi, T | 1 |
| Terkeltaub, R | 1 |
| Ellison, RC | 1 |
| Hunt, S | 1 |
| He, P | 1 |
| Xie, XH | 1 |
| Ding, YP | 1 |
| Chen, XL | 1 |
| Kincl, V | 1 |
| Panovsky, R | 1 |
| Meluzin, J | 1 |
| Semenka, J | 1 |
| Groch, L | 1 |
| Tomcikova, D | 1 |
| Jarkovsky, J | 1 |
| Dusek, L | 1 |
| Secco, GG | 1 |
| Santagostino, M | 1 |
| Venegoni, L | 1 |
| Iorio, S | 1 |
| Coppo, L | 1 |
| Di Mario, C | 1 |
| Demirkan, B | 1 |
| Güray, Y | 1 |
| Güray, Ü | 1 |
| Turak, O | 1 |
| Hajro, E | 1 |
| Korkmaz, S | 1 |
| Park, SH | 1 |
| Shin, WY | 1 |
| Lee, EY | 1 |
| Gil, HW | 1 |
| Lee, SJ | 1 |
| Jin, DK | 1 |
| Hong, SY | 1 |
| Ikizek, M | 1 |
| Selcoki, Y | 2 |
| Uysal, S | 1 |
| Armutcu, F | 1 |
| Eryonucu, B | 2 |
| Zapolski, T | 1 |
| Waciński, P | 1 |
| Kondracki, B | 1 |
| Rychta, E | 1 |
| Buraczyńska, MJ | 1 |
| Wysokiński, A | 1 |
| Myśliwiec, M | 1 |
| Silver, SA | 1 |
| Huang, M | 1 |
| Nash, MM | 1 |
| Prasad, GV | 1 |
| Matheus, AS | 1 |
| Tibiriçá, E | 1 |
| da Silva, PB | 1 |
| de Fátima Bevilácqua da Matta, M | 1 |
| Gomes, MB | 1 |
| Silbernagel, G | 1 |
| Hoffmann, MM | 1 |
| Grammer, TB | 1 |
| Boehm, BO | 1 |
| März, W | 1 |
| Kalay, N | 2 |
| Aytekin, M | 1 |
| Ozbek, K | 1 |
| Karayakalı, M | 1 |
| Söğüt, E | 1 |
| Altunkas, F | 1 |
| Oztürk, A | 1 |
| Koç, F | 1 |
| Arimura, T | 1 |
| Miura, S | 2 |
| Sugihara, M | 2 |
| Iwata, A | 2 |
| Yamagishi, S | 1 |
| Saku, K | 3 |
| Zhang, Z | 1 |
| Bian, L | 1 |
| Choi, Y | 1 |
| Kim, KN | 1 |
| Kim, KM | 1 |
| Lee, DJ | 1 |
| Joo, NS | 1 |
| Al-Meshaweh, AF | 1 |
| Jafar, Y | 1 |
| Asem, M | 1 |
| Akanji, AO | 1 |
| Orscelik, O | 1 |
| Elcik, D | 1 |
| Ocak, A | 1 |
| Inanc, MT | 1 |
| Kasapkara, HA | 1 |
| Oguzhan, A | 1 |
| Eryol, NK | 1 |
| Xiong, Z | 1 |
| Qian, X | 1 |
| Wu, Z | 1 |
| Lewis, CE | 1 |
| Mikuls, TR | 1 |
| Saag, KG | 1 |
| Krishnan, E | 1 |
| Pandya, BJ | 1 |
| Lingala, B | 1 |
| Hariri, A | 1 |
| Dabbous, O | 1 |
| Jolly, SE | 1 |
| Mete, M | 1 |
| Ebbesson, SOE | 1 |
| Voruganti, VS | 1 |
| Comuzzie, AG | 1 |
| Howard, BV | 1 |
| Umans, JG | 1 |
| Tanaka, T | 1 |
| Ike, A | 1 |
| Nishikawa, H | 1 |
| Kawamura, A | 1 |
| Hadamitzky, M | 3 |
| Haase, HU | 3 |
| Birkmeier, KA | 1 |
| Shen, CC | 1 |
| Chung, HT | 1 |
| Huang, YL | 1 |
| Yeh, KW | 1 |
| Huang, JL | 1 |
| Jeemon, P | 1 |
| Prabhakaran, D | 1 |
| Zheng, NC | 1 |
| Lai, CP | 1 |
| Jaiteh, LE | 1 |
| Papežíková, I | 1 |
| Pekarová, M | 1 |
| Kolářová, H | 1 |
| Klinke, A | 1 |
| Lau, D | 1 |
| Baldus, S | 1 |
| Lojek, A | 1 |
| Kubala, L | 1 |
| Atar, AI | 1 |
| Yılmaz, OC | 1 |
| Akın, K | 1 |
| Er, O | 1 |
| Eisen, A | 1 |
| Benderly, M | 1 |
| Goldbourt, U | 1 |
| Haim, M | 1 |
| DREYFUSS, F | 1 |
| MCKECHNIE, JK | 1 |
| DAVIDSON, FJ | 1 |
| GERTLER, MM | 2 |
| WHITE, PD | 1 |
| CADY, LD | 1 |
| WHITER, HH | 1 |
| DENBOROUGH, MA | 1 |
| CLARKE, P | 1 |
| PATERSON, B | 1 |
| Yasumasu, T | 1 |
| Takahara, K | 1 |
| Sadayasu, T | 1 |
| Date, H | 1 |
| Isozumi, K | 1 |
| Kouzuma, R | 1 |
| Nakashima, Y | 1 |
| GARN, SM | 1 |
| LEVINE, SA | 1 |
| Hayden, MR | 1 |
| Tyagi, SC | 1 |
| Wheeler, JG | 1 |
| Juzwishin, KD | 1 |
| Eiriksdottir, G | 1 |
| Gudnason, V | 1 |
| Danesh, J | 1 |
| Yardim-Akaydin, S | 2 |
| Kesimer, M | 1 |
| Imren, E | 2 |
| Sepici, A | 1 |
| Simşek, B | 3 |
| Torun, M | 3 |
| Ozkan, Y | 1 |
| Orakzai, R | 1 |
| Meneghelo, RS | 1 |
| Carvalho, JA | 1 |
| Blumenthal, RS | 1 |
| Coutinho, Tde A | 1 |
| Turner, ST | 1 |
| Peyser, PA | 1 |
| Bielak, LF | 1 |
| Sheedy, PF | 1 |
| Kullo, IJ | 1 |
| Jelić-Ivanović, Z | 1 |
| Memon, L | 1 |
| Spasojević-Kalimanovska, V | 1 |
| Bogavac-Stanojević, N | 1 |
| Spasić, S | 1 |
| Kaneshi, T | 1 |
| Yoshida, T | 1 |
| Ohshiro, T | 1 |
| Nagasaki, H | 1 |
| Asato, Y | 1 |
| Ohta, T | 1 |
| Hjortnaes, J | 1 |
| Algra, A | 1 |
| Olijhoek, J | 1 |
| Huisman, M | 1 |
| Jacobs, J | 1 |
| van der Graaf, Y | 1 |
| Visseren, F | 1 |
| Neureuther, K | 1 |
| Wiedmann, S | 1 |
| Sedlacek, K | 1 |
| Baessler, A | 1 |
| Fischer, M | 1 |
| Weber, S | 1 |
| Kaess, B | 1 |
| Bozbaş, H | 1 |
| Yildirir, A | 1 |
| Pirat, B | 1 |
| Eroğlu, S | 1 |
| Korkmaz, ME | 1 |
| Atar, I | 1 |
| Ulus, T | 1 |
| Aydinalp, A | 1 |
| Ozin, B | 1 |
| Müderrisoğlu, H | 1 |
| Tavil, Y | 1 |
| Sen, N | 1 |
| Hizal, F | 1 |
| Açikgöz, SK | 1 |
| Taşoğlu, I | 1 |
| Topal, S | 1 |
| Yalçin, MR | 1 |
| Bergstrand, L | 1 |
| Tsutsumi, Z | 1 |
| Yamamoto, T | 1 |
| Takahashi, S | 1 |
| Moriwaki, Y | 1 |
| Higashino, K | 1 |
| Ariza, CR | 1 |
| Frati, AC | 1 |
| Gómez, G | 1 |
| Almazán, A | 1 |
| Wannamethee, SG | 1 |
| Shaper, AG | 1 |
| Whincup, PH | 1 |
| Yoneda, T | 1 |
| Kawakami, H | 1 |
| Kita, A | 1 |
| Tagashira, S | 1 |
| Matsuura, M | 1 |
| Matsuoka, Y | 1 |
| Yardim, S | 1 |
| Burgaz, S | 1 |
| Yoo, JH | 1 |
| Park, JE | 1 |
| Hong, KP | 1 |
| Kim, DK | 1 |
| Lee, WR | 1 |
| Park, SC | 1 |
| Saito, D | 1 |
| Shiraki, T | 1 |
| Oka, T | 1 |
| Kajiyama, A | 1 |
| Doi, M | 1 |
| Masaka, T | 1 |
| Takezako, T | 1 |
| Zhang, B | 1 |
| Shirai, K | 1 |
| Arakawa, K | 1 |
| Moriarity, JT | 1 |
| Folsom, AR | 1 |
| Iribarren, C | 1 |
| Nieto, FJ | 1 |
| Rosamond, WD | 1 |
| Bickel, C | 1 |
| Rupprecht, HJ | 1 |
| Blankenberg, S | 1 |
| Rippin, G | 1 |
| Hafner, G | 1 |
| Daunhauer, A | 1 |
| Hofmann, KP | 1 |
| Meyer, J | 1 |
| Hiyamuta, K | 1 |
| Toshima, H | 1 |
| Koga, Y | 1 |
| Nakayama, H | 1 |
| Yamaga, A | 1 |
| Shiraishi, A | 1 |
| Maruyama, H | 1 |
| Hidaka, Y | 1 |
| Ueno, T | 1 |
| Yoshiga, O | 1 |
| Mesquita, MF | 1 |
| Seabra, MP | 1 |
| Halpern, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intensified Antiplatelet Therapy in Post-PCI Patients With High On-treatment Platelet Reactivity: the OPTIMA-2 Trial[NCT01955200] | Phase 4 | 1,724 participants (Actual) | Interventional | 2013-10-05 | Completed | ||
| Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 DiabetesL a Open-label Trial[NCT02502071] | Phase 4 | 45 participants (Actual) | Interventional | 2017-01-31 | Completed | ||
| Reduced Serum Bilirubin Levels in Patients With Normal-tension Glaucoma[NCT03387306] | 76 participants (Actual) | Observational | 2010-01-31 | Completed | |||
| Value of Uric Acid as Early Predictor of Lupus Nephritis in Assiut University Hospital[NCT05402735] | 100 participants (Anticipated) | Observational | 2022-06-15 | Recruiting | |||
| Endothelin in the Coronary Circulation in Early Atherosclerosis in Humans[NCT00271492] | Phase 3 | 200 participants (Actual) | Interventional | 2001-07-31 | Completed | ||
| Comparisons Of Inflammatory Biomarkers And Cardiovascular Risk Scores Before And After Conversion To Full Dose Myfortic® Using Two Hour Neoral® Monitoring.[NCT02058875] | Phase 4 | 0 participants (Actual) | Interventional | 2014-02-28 | Withdrawn (stopped due to The study funder retracted their grant funding offer before contract signed.) | ||
| Effects of Low Intensity Aerobic Exercise Training on the Microvascular Endothelial Function of Patients With Type 1 Diabetes: a Non-pharmacological Interventional Study[NCT02441504] | 22 participants (Actual) | Interventional | 2014-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Urine uric acid crystals were identified by polarized microscopy (Polarized light imaging Zeiss Axiovert 135; 0.3NA objective), and pictures were captured from each urine sample. UA crystals were defined dichotomously as being present or absent. (NCT02502071)
Timeframe: Day 1 (pre-therapy) and Day 2 (post-therapy)
| Intervention | participants (Number) | |
|---|---|---|
| Day 1 (pre-therapy) | Day 2 (post-therapy) | |
| Sodium Bicarbonate | 14 | 3 |
Urine uric acid were evaluated using a QuantiChrom UA kit assay (DIUA-250) with quantitative colorimetric UA determination at 590 nm (BioAssay System, California, USA). (NCT02502071)
Timeframe: Day 1 (pre-therapy) and Day 2 (post-therapy)
| Intervention | mg/dl (Geometric Mean) | |
|---|---|---|
| Day 1 (pre-therapy) | Day 2 (post-therapy) | |
| Sodium Bicarbonate | 23.81 | 22.30 |
13 reviews available for uric acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
The association between hyperuricemia and coronary artery calcification development: A systematic review and meta-analysis.
Topics: Biomarkers; Coronary Artery Disease; Coronary Vessels; Disease Progression; Global Health; Humans; H | 2019 |
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease.
Topics: Coronary Artery Disease; Genome-Wide Association Study; Humans; Hyperuricemia; Polymorphism, Genetic | 2021 |
The Role of Uric Acid in the Acute Myocardial Infarction: A Narrative Review.
Topics: Coronary Artery Disease; Humans; Myocardial Infarction; Risk Factors; Uric Acid | 2022 |
Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Humans; Hypertension; Prognosis; Risk Factors; Str | 2021 |
Uric acid and coronary artery disease: An elusive link deserving further attention.
Topics: Coronary Artery Disease; Humans; Hypertension; Hyperuricemia; Risk Factors; Uric Acid | 2016 |
Association between hyperuricemia and clinical adverse outcomes after percutaneous coronary intervention: A meta-analysis.
Topics: Coronary Artery Disease; Global Health; Humans; Hyperuricemia; Incidence; Percutaneous Coronary Inte | 2015 |
Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: A meta-analysis.
Topics: Aged; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Mortality | 2016 |
Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies.
Topics: Coronary Artery Disease; Global Health; Humans; Hyperuricemia; Incidence; Prospective Studies; Risk | 2016 |
Uric acid: A marker of increased cardiovascular risk.
Topics: Biomarkers; Cardiovascular Diseases; Carotid Artery Diseases; Coronary Artery Disease; Female; Heart | 2009 |
Using new tools to define the genetic underpinnings of risky traits associated with coronary artery disease: the SardiNIA study.
Topics: Blood Flow Velocity; Blood Glucose; Coronary Artery Disease; Genetic Carrier Screening; Genetic Mark | 2009 |
Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review.
Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Antioxidants; Cholesterol, HDL; Coronary A | 2005 |
Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Coronary Artery Disease; Fem | 2005 |
[Gout and atherosclerosis].
Topics: Alcohol Drinking; Coronary Artery Disease; Gout; Humans; Hyperlipidemias; Hypertension; Obesity; Pla | 1996 |
9 trials available for uric acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Topics: Aged; Allopurinol; Coronary Artery Disease; Female; Gout; Humans; Male; Myocardial Infarction; Myoca | 2022 |
The effects of rice bran oil on left ventricular systolic function, cardiometabolic risk factors and inflammatory mediators in men with coronary artery disease: a randomized clinical trial.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Reactive Protein; Cardiometabolic Risk Factors; Coronary | 2021 |
Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study.
Topics: Adult; Calcinosis; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 1; Diabetic An | 2014 |
Cardiovascular risk factors and total serum antioxidant capacity in healthy men and in men with coronary heart disease.
Topics: Adult; Aged; Antioxidants; Biomarkers; Comorbidity; Coronary Artery Disease; Humans; Incidence; Men; | 2014 |
Almond supplementation reduces serum uric acid in coronary artery disease patients: a randomized controlled trial.
Topics: Biomarkers; Blood Pressure; Breakfast; Coronary Artery Disease; Diet; Dietary Supplements; Female; H | 2016 |
Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease.
Topics: Aged; Blood Flow Velocity; Coronary Artery Disease; Endothelium, Vascular; Exercise Therapy; Exercis | 2008 |
Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.
Topics: Adult; Atrasentan; Blood Glucose; Blood Pressure; Coronary Artery Disease; Coronary Circulation; End | 2010 |
Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
Topics: Aged; Bezafibrate; Blood Glucose; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; | 2010 |
Urate oxidation during percutaneous transluminal coronary angioplasty and thrombolysis in patients with coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Oxidatio | 2005 |
188 other studies available for uric acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention.
Topics: Coronary Artery Disease; Humans; Incidence; Percutaneous Coronary Intervention; Retrospective Studie | 2021 |
Prognostic Significance of Uric Acid in Patients with Obstructive and Nonobstructive Coronary Artery Disease Undergoing D-SPECT.
Topics: China; Coronary Artery Disease; Female; Humans; Male; Prognosis; Risk Factors; Tomography, Emission- | 2021 |
Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
Topics: Acute Coronary Syndrome; Coronary Artery Disease; Humans; Hypertension; Percutaneous Coronary Interv | 2022 |
Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
Topics: Biomarkers; Coronary Artery Disease; Heart Failure; Humans; Natriuretic Peptide, Brain; Peptide Frag | 2022 |
Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
Topics: Biomarkers; Coronary Artery Disease; Heart Failure; Humans; Natriuretic Peptide, Brain; Peptide Frag | 2022 |
Atherogenic index of plasma predicts coronary artery disease severity and major adverse cardiac events in absence of conventional risk factors.
Topics: C-Reactive Protein; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Glycated Hemogl | 2022 |
Correlation Between Serum Uric Acid Levels and Coronary Plaque Characteristics on Optical Coherence Tomography.
Topics: Acute Coronary Syndrome; Calcinosis; Coronary Angiography; Coronary Artery Disease; Coronary Vessels | 2022 |
Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease.
Topics: Biomarkers; Blood Pressure; Coronary Artery Disease; Female; Humans; Prospective Studies; Uric Acid; | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Changes in Serum Uric Acid Level in Acute Myocardial Infarction Patients.
Topics: Bangladesh; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Humans; Myocardi | 2023 |
Correlation of elevated serum uric acid with coronary artery disease in Xinjiang, China: A retrospective case-control study.
Topics: Case-Control Studies; China; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Female | 2023 |
Overnight changes in uric acid, xanthine oxidoreductase and oxidative stress levels and their relationships with sleep-disordered breathing in patients with coronary artery disease.
Topics: Coronary Artery Disease; Humans; Hyperuricemia; Male; Oxidative Stress; Sleep Apnea Syndromes; Uric | 2023 |
Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Biomarkers; C-Reactive Protein; Coronary Artery Disease; COVID-19; Endothel | 2023 |
Association between paroxysmal or persistent atrial fibrillation and hyperuricemia in patients who underwent coronary computed tomography angiography: from the FU-CCTA-AF Registry.
Topics: Atrial Fibrillation; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; | 2023 |
Can we obtain a reliable marker that shows the hypoxic burden in patients with sleep disordered breathing?
Topics: Coronary Artery Disease; Humans; Hypoxia; Sleep Apnea Syndromes; Uric Acid; Xanthine Dehydrogenase | 2023 |
Uric Acid Levels, Number of Standard Modifiable Cardiovascular Risk Factors, and Prognosis in Patients With Coronary Artery Disease: A Large Cohort Study in Asia.
Topics: Asia; Cardiovascular Diseases; Cohort Studies; Coronary Artery Disease; Heart Disease Risk Factors; | 2023 |
Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Per | 2023 |
Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease.
Topics: Coronary Artery Disease; Gout; Humans; Male; Uric Acid; Xanthine; Xanthine Dehydrogenase | 2023 |
Uric acid and evaluate the coronary vascular stenosis gensini score correlation research and in gender differences.
Topics: Aged; C-Reactive Protein; Constriction, Pathologic; Coronary Angiography; Coronary Artery Disease; C | 2023 |
Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease.
Topics: Biomarkers; Coronary Artery Disease; Creatinine; Cross-Sectional Studies; Cysteine; Female; Humans; | 2020 |
The relationship between a combination of vitamin D deficiency and hyperuricemia and the severity of coronary artery disease in myocardial infarction patients.
Topics: Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; M | 2020 |
A Comparative Study of Correlation between Serum Uric Acid Levels and Severity of Coronary Artery Disease.
Topics: Coronary Angiography; Coronary Artery Disease; Humans; Risk Factors; Uric Acid | 2020 |
Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
Topics: Aged; Aged, 80 and over; Biomarkers; Coronary Artery Disease; Female; Heart Failure; Humans; Hyperur | 2020 |
Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot.
Topics: Carotid Intima-Media Thickness; Carotid Stenosis; Cohort Studies; Coronary Artery Disease; Female; H | 2020 |
Sex differences in uric acid and NT-pro BNP assessments during coronary severity.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Biomarkers; Coronary Angiography; Coronary Artery | 2020 |
[Related factors and the long-term outcome after percutaneous coronary intervention of premature acute myocardial infarction].
Topics: Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneou | 2020 |
Serum uric acid level negatively correlated with the prevalence of clopidogrel low response in patients undergoing antiplatelet treatment with aspirin and clopidogrel.
Topics: Aged; Aged, 80 and over; Aspirin; Biomarkers; Clopidogrel; Coronary Artery Disease; Cross-Sectional | 2020 |
Elevated postoperative serum uric acid is associated with major adverse events following coronary artery bypass grafting.
Topics: Aged; Biomarkers; Coronary Artery Bypass; Coronary Artery Disease; Female; Hospital Mortality; Human | 2020 |
Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary intervention.
Topics: Blood Platelets; Coronary Angiography; Coronary Artery Disease; Humans; Percutaneous Coronary Interv | 2021 |
Relevance of Physical Fitness and Cardiovascular Disease Risk.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Corticotropin-Releasing Hormone; Female; Humans; M | 2021 |
Higher serum level of Cystatin C: An additional risk factor of CAD.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cholesterol; Coronary Artery Disease; Cystatin C; Female | 2021 |
Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia.
Topics: Adult; Aged; Biomarkers; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disease; Coronar | 2021 |
Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular diastolic parameter.
Topics: Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Diastole; | 2021 |
Genetically predicted serum uric acid levels and the risk of coronary artery disease in patients with diabetes: A Mendelian randomization study.
Topics: Biomarkers; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus; Genome-Wide Associatio | 2021 |
Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: A single-center cross-sectional study.
Topics: Adult; Aged; Asymptomatic Diseases; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans | 2017 |
Correlation between serum uric acid levels and residual platelet reactivity in patients undergoing PCI.
Topics: Aged; Biomarkers; Blood Platelets; Coronary Artery Disease; Female; Humans; Hyperuricemia; Male; Mid | 2017 |
Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; | 2017 |
Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery.
Topics: Age Factors; Aged; Biomarkers; Cardiac Rehabilitation; Comorbidity; Coronary Artery Bypass; Coronary | 2018 |
The association between uric acid levels and different clinical manifestations of coronary artery disease.
Topics: Adult; Aged; Coronary Artery Disease; Coronary Vessels; Correlation of Data; Female; Humans; Male; M | 2018 |
Long-term supplementation with folic acid and vitamin B-12 has no effect on circulating uric acid concentrations in Norwegian patients with coronary artery disease.
Topics: China; Coronary Artery Disease; Folic Acid; Humans; Norway; Primary Prevention; Stroke; Uric Acid; V | 2018 |
Reply to J Dierkes et al.
Topics: Coronary Artery Disease; Folic Acid; Humans; Uric Acid; Vitamin B 12; Vitamins | 2018 |
Elevated serum uric acid predicts the development of moderate coronary artery calcification independent of conventional cardiovascular risk factors.
Topics: Calcinosis; Cardiovascular Diseases; Coronary Artery Disease; Coronary Vessels; Female; Follow-Up St | 2018 |
Uric acid as an independent predictor of coronary artery disease in essential hypertension: Data from an 8-year-follow-up study.
Topics: Biomarkers; Coronary Artery Disease; Essential Hypertension; Female; Humans; Incidence; Kaplan-Meier | 2018 |
Hyperuricemia and severity of coronary artery disease: An observational study in adults 35 years of age and younger with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adolescent; Adult; Age Factors; Biomarkers; China; Coronary Artery Disease; | 2019 |
Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Endotheliu | 2018 |
Elevated serum uric acid: a marker and mediator of increased stress on myocardium.
Topics: Biomarkers; Coronary Artery Disease; Humans; Myocardium; Uric Acid | 2018 |
Significance of asymptomatic hyperuricemia in patients after coronary events.
Topics: Coronary Artery Disease; Demography; Female; Humans; Hyperuricemia; Male; Middle Aged; Risk Factors; | 2018 |
Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.
Topics: Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Humans | 2018 |
Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease.
Topics: Aged; Angina, Stable; Biomarkers; Coronary Angiography; Coronary Artery Disease; Female; Humans; Hyp | 2019 |
Hyperuricemia and smoking in young adults suspected of coronary artery disease ≤ 35 years of age: a hospital-based observational study.
Topics: Adolescent; Adult; Age of Onset; Beijing; Biomarkers; Coronary Artery Disease; Coronary Stenosis; Fe | 2018 |
Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Child; Coronary Artery Disease; Female; Geno | 2019 |
Evaluation of the association between hyperuricemia and coronary artery disease: A STROBE-compliant article.
Topics: Aged; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Female; Humans; Hyperuricemia; | 2018 |
Serum Uric Acid Is Independently Associated with Coronary Calcification in an Asymptomatic Population.
Topics: Aged; Asymptomatic Diseases; Biomarkers; Computed Tomography Angiography; Coronary Angiography; Coro | 2019 |
Serum Uric Acid as an Independent Risk Factor for the Presence and Severity of Early-Onset Coronary Artery Disease: A Case-Control Study.
Topics: Acute Coronary Syndrome; Adult; Age of Onset; Body Weight; Case-Control Studies; Coronary Artery Dis | 2018 |
Implications of Hyperuricemia in Severe Coronary Artery Disease.
Topics: Aged; Cohort Studies; Coronary Artery Disease; Female; Humans; Hyperuricemia; Male; Middle Aged; Pro | 2019 |
Composite acute phase glycoproteins with coronary artery calcification depends on metabolic syndrome presence - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Topics: Acute-Phase Proteins; Adult; Biomarkers; Brazil; C-Reactive Protein; Coronary Artery Disease; Corona | 2019 |
Association between serum uric acid levels and coronary artery disease in different age and gender: a cross-sectional study.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Coronary Artery Disease; Cross-Sectional Studies; | 2019 |
Very High Serum Uric Acid Levels, Plaque Morphology, and the Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Coronary Artery Disease; Humans; Plaque, Atherosclerotic; Tomography, Optic | 2018 |
Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Artery Disease; | 2019 |
Association of Uric Acid and C-reactive Protein with the Severity of Coronary Artery Disease Using SYNTAX Score and Clinical SYNTAX Score.
Topics: Aged; C-Reactive Protein; Coronary Artery Disease; Female; Humans; Logistic Models; Male; Middle Age | 2019 |
Association between Serum Uric Acid Level with Presence and Severity of Coronary Artery Disease.
Topics: Adolescent; Aged; Coronary Angiography; Coronary Artery Disease; Humans; Middle Aged; Uric Acid | 2019 |
Serum uric acid level and subclinical coronary atherosclerosis in asymptomatic individuals: An observational cohort study.
Topics: Asymptomatic Diseases; Biomarkers; Computed Tomography Angiography; Coronary Angiography; Coronary A | 2019 |
Relation of serum uric acid and body mass index to mortality in high-risk patients with established coronary artery disease: a report from the ET-CHD registry, 1997-2006.
Topics: Aged; Body Mass Index; Cohort Studies; Coronary Artery Disease; Female; Forecasting; Humans; Male; M | 2013 |
The association between plasma uric acid level and cardiovascular events in patients with stable coronary artery disease: a short-term follow-up study.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Follow-Up Studies; Humans; Risk Factors; Uric Acid | 2013 |
Longitudinal association between serum urate and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
Topics: Adolescent; Adult; Age Factors; Atherosclerosis; Biomarkers; Body Mass Index; Coronary Artery Diseas | 2013 |
Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease.
Topics: Biomarkers; Collateral Circulation; Coronary Angiography; Coronary Artery Disease; Coronary Circulat | 2014 |
A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Dis | 2013 |
[Relation between uric acid and coronary artery calcification:a community-based cross-sectional survey among Beijing natural population].
Topics: Adult; Aged; China; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Male; Middle A | 2013 |
No relevant association between coronary artery ectasia and mean platelet volume, gamma-glutamyltransferase and uric acid levels.
Topics: Coronary Artery Disease; Dilatation, Pathologic; Female; gamma-Glutamyltransferase; Humans; Male; Me | 2013 |
Uric acid as a cardiovascular risk factor or not?
Topics: Biomarkers; Collateral Circulation; Coronary Artery Disease; Coronary Circulation; Female; Humans; M | 2014 |
The association of serum uric acid level with coronary collateral circulation should be interpreted together with renal function and cardiovascular medications in stable coronary artery disease.
Topics: Biomarkers; Collateral Circulation; Coronary Artery Disease; Coronary Circulation; Female; Humans; M | 2014 |
Determinants that may affect serum uric acid levels.
Topics: Biomarkers; Collateral Circulation; Coronary Artery Disease; Coronary Circulation; Female; Humans; M | 2014 |
The paradox of uric acid in cardiovascular diseases.
Topics: Biomarkers; Collateral Circulation; Coronary Artery Disease; Coronary Circulation; Female; Humans; M | 2014 |
Uric acid level and erectile dysfunction in patients with coronary artery disease.
Topics: Aged; C-Reactive Protein; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus; Erect | 2014 |
Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy.
Topics: Aged; Angina, Unstable; Biomarkers; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-C | 2014 |
Hyperuricaemia: the unintended consequence of insulin resistance/compensatory hyperinsulinaemia. Philanthropy gone awry.
Topics: Atherosclerosis; Coronary Artery Disease; Female; Humans; Male; Uric Acid | 2014 |
Relation of serum uric acid to severity and progression of coronary artery calcium in postmenopausal White and Filipino women (from the Rancho Bernardo study).
Topics: Aged; Aged, 80 and over; Asian People; Biomarkers; Calcinosis; California; Coronary Artery Disease; | 2014 |
Association of glomerular filtration rate with slow coronary flow in patients with normal to mildly impaired renal function.
Topics: Adult; Biomarkers; Case-Control Studies; Collateral Circulation; Coronary Angiography; Coronary Arte | 2014 |
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diabetes Mel | 2014 |
Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease.
Topics: Aged; Arterial Occlusive Diseases; Coronary Artery Disease; Female; Humans; Kaplan-Meier Estimate; M | 2014 |
The anti-inflammatory and antioxidant effects of pravastatin and nebivolol in rat aorta.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Aorta; Ceruloplasmin; Cholesterol; Coronary Artery | 2014 |
Serum uric acid as a predictor of vascular complications in diabetes: an additional case for neuropathy.
Topics: Coronary Artery Disease; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Humans; Male; Uri | 2014 |
A cross-sectional analysis of the relationship between uric acid and coronary atherosclerosis in patients with suspected coronary artery disease in China.
Topics: Aged; Biomarkers; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Disease; Cor | 2014 |
Association of serum uric acid and coronary artery disease in premenopausal women.
Topics: Adult; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Hyper | 2014 |
Retinol-binding protein 4 as a novel risk factor for cardiovascular disease in patients with coronary artery disease and hyperinsulinemia.
Topics: Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies | 2014 |
Elevated high sensitivity C-reactive protein and uric acid levels in coronary artery ectasia.
Topics: Aged; Animals; C-Reactive Protein; Coronary Artery Disease; Female; Humans; Immunoassay; Male; Middl | 2014 |
Correlation of serum lipids with uric acid and blood sugar in normal males.
Topics: Adult; Blood Glucose; Cholesterol; Coronary Artery Disease; Coronary Disease; Humans; Lipids; Longit | 1965 |
Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin, and neutrophil-to-lymphocyte ratio in patients with coronary artery disease.
Topics: Bilirubin; Biomarkers; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disease; Cross-Sec | 2015 |
Lipoprotein subfractions partly mediate the association between serum uric acid and coronary artery disease.
Topics: Coronary Artery Disease; Female; Humans; Lipoproteins; Male; Middle Aged; Uric Acid | 2015 |
Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease.
Topics: Adult; Asian People; China; Coronary Angiography; Coronary Artery Disease; Echocardiography; Female; | 2015 |
Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Age Factors; Biomarkers; C-Reactive Protein; | 2015 |
The relationship between serum uric acid levels and angiographic severity of coronary heart disease.
Topics: Adult; Age Factors; Aged; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middl | 2015 |
Serum uric acid: an independent predictive marker for coronary artery disease.
Topics: Coronary Artery Disease; Female; Humans; Hyperlipidemias; Hypertension; Male; Uric Acid | 2015 |
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study.
Topics: Aged; Aged, 80 and over; Biomarkers; Chi-Square Distribution; Coronary Angiography; Coronary Artery | 2015 |
A coronary artery disease-associated SNP rs6903956 contributed to asymptomatic hyperuricemia susceptibility in Han Chinese.
Topics: Asian People; Asymptomatic Diseases; Case-Control Studies; China; Coronary Artery Disease; Female; G | 2015 |
Elevated serum uric acid is associated with vascular inflammation but not coronary artery calcification in the healthy octogenarians: the Brazilian study on healthy aging.
Topics: Aged, 80 and over; Biomarkers; Brazil; C-Reactive Protein; Coronary Artery Disease; Coronary Vessels | 2016 |
[Relationship between serum level of uric acid and benign paroxysmal positional vertigo].
Topics: Benign Paroxysmal Positional Vertigo; Blood Pressure; Blood Urea Nitrogen; Coronary Artery Disease; | 2015 |
Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis.
Topics: Adiponectin; Adipose Tissue; Aged; Biomarkers; Cardiac Resynchronization Therapy; Carrier Proteins; | 2015 |
Prognostic Significance of Uric Acid Levels in Ischemic Stroke Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Brain Ischemia; Chi-Square Distrib | 2016 |
Serum Urate and Incident Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Topics: Adolescent; Adult; Biomarkers; Cardiovascular Diseases; Cohort Studies; Coronary Artery Disease; Cor | 2015 |
Does high serum uric acid level cause aspirin resistance?
Topics: Aged; Angina Pectoris; Aspirin; Biomarkers; Blood Cell Count; Blood Glucose; C-Reactive Protein; Cor | 2016 |
Effects of Serum Uric Acid on Estimated GFR in Cardiac Surgery Patients: A Pilot Study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Biomarkers; Cardiac Surgical Procedures; Case-Contr | 2015 |
Silent Monosodium Urate Crystal Deposits Are Associated With Severe Coronary Calcification in Asymptomatic Hyperuricemia: An Exploratory Study.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Coronary Artery Disease; Cross-Sectional Studies; Cr | 2016 |
Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease.
Topics: Adenosine; Aged; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperh | 2016 |
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.
Topics: Adenosine; Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Coronary Artery Disease; Female; F | 2016 |
Impact of Serum Uric Acid Levels on Coronary Plaque Stability Evaluated Using Integrated Backscatter Intravascular Ultrasound in Patients with Coronary Artery Disease.
Topics: Aged; Coronary Artery Disease; Female; Humans; Image Interpretation, Computer-Assisted; Japan; Male; | 2016 |
Sex differences in the association between serum uric acid and cardiac mortality in Asian patients with established coronary artery disease: A revisit of the ET-CHD registry in Taiwan, 1997-2003.
Topics: Coronary Artery Disease; Coronary Disease; Humans; Registries; Risk Factors; Sex Characteristics; Ta | 2016 |
Association between Serum Uric Acid and Mortality among Chinese Patients with Coronary Artery Disease.
Topics: Adult; Aged; Aged, 80 and over; Asian People; China; Cohort Studies; Coronary Artery Disease; Female | 2016 |
The Prognostic Role of Serum Uric Acid (SUA) in Coronary Artery Disease: PerSUAsive Data Plea for a Large Morbidity-Mortality Trial.
Topics: Coronary Angiography; Coronary Artery Disease; Humans; Prognosis; Risk Factors; Uric Acid | 2016 |
Is Serum Uric Acid Level Correlated with Erectile Dysfunction in Coronary Artery Disease Patients?
Topics: Adult; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Erectile Dysfunction; Fe | 2016 |
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aspirin; Biomarkers; Chi-Square Distribution; Clopidogrel; | 2016 |
[Relationship between uric acid and coronary artery disease].
Topics: Coronary Artery Disease; Humans; Risk Factors; Uric Acid | 2016 |
Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji Cohort.
Topics: Aged; Biomarkers; China; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hyperuricemia; | 2016 |
Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.
Topics: Aged; Biomarkers; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Endothelium, Vasc | 2017 |
The burden of major adverse cardiac events in patients with coronary artery disease.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Area Under Curve; Chi-Square Distribution; | 2017 |
Small arterial elasticity predicts the extent of coronary artery disease: Relationship with serum uric acid.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Elasticity; Female; Hum | 2009 |
The relationship between coronary artery disease and uric acid levels in young patients with acute myocardial infarction.
Topics: Adult; Antithrombin III; Body Mass Index; Coronary Angiography; Coronary Artery Disease; Creatinine; | 2008 |
Evaluation of characteristics and degree of remodeling in coronary atherosclerotic lesions by 64-detector multislice computed tomography (MSCT).
Topics: Adult; Aged; Aged, 80 and over; Algorithms; C-Reactive Protein; Coronary Angiography; Coronary Arter | 2009 |
Association between serum uric acid and perioperative and late cardiovascular outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery.
Topics: Aged; Biomarkers; Coronary Artery Disease; Elective Surgical Procedures; Female; Humans; Logistic Mo | 2008 |
Systemic correlates of angiographic coronary artery disease.
Topics: Aged; Blood Glucose; Body Mass Index; Calcium; Cholesterol; Coronary Angiography; Coronary Artery Di | 2009 |
Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
Topics: Aged; Analysis of Variance; Bezafibrate; Biomarkers; C-Reactive Protein; Cohort Studies; Confidence | 2009 |
Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden.
Topics: Adult; Aged; Aging; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; | 2009 |
Serum uric acid for risk stratification of patients with coronary artery disease.
Topics: Aged; Biomarkers; Coronary Artery Disease; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged | 2009 |
Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding | 2009 |
Clinical value of serum uric Acid in patients with suspected coronary artery disease.
Topics: Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Female; Humans; Insulin Resistance; | 2010 |
The association between serum uric acid level and coronary artery disease.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Risk Factors | 2010 |
The association of serum uric acid levels with outcomes following percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Confidence Intervals; Coronary Artery Disease; | 2010 |
Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease.
Topics: Adult; Coronary Artery Disease; Disease Progression; Female; Humans; Kidney Diseases; Male; Middle A | 2010 |
Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography.
Topics: Aged; Algorithms; Cardiology; Coronary Artery Disease; Coronary Vessels; Cross-Sectional Studies; Fe | 2010 |
Serum urate is not associated with coronary artery calcification: the NHLBI Family Heart Study.
Topics: Calcinosis; Coronary Artery Disease; Female; Humans; Male; Middle Aged; National Heart, Lung, and Bl | 2011 |
[Correlation between high sensitive C-reactive protein, lipoprotein(a), blood uric acid and severity of coronary artery disease].
Topics: Aged; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Female; Humans; Lipoprotein(a); | 2010 |
Association between laboratory markers and presence of coronary artery disease.
Topics: Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Coronary Angiography; Coronar | 2010 |
Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study.
Topics: Aged; Aged, 80 and over; Carotid Intima-Media Thickness; Cohort Studies; Coronary Angiography; Coron | 2012 |
The relationship between saphenous coronary bypass graft occlusion and serum gamma-glutamyltransferase activity.
Topics: Aged; C-Reactive Protein; Cholesterol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery | 2010 |
The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Creatinine; Diab | 2011 |
Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.
Topics: Aged; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female | 2011 |
Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Topics: Aged; Biomarkers; Coronary Artery Disease; Diabetes Mellitus; Female; Humans; Hyperuricemia; Inflamm | 2011 |
[Restriction of fructose intake can prevent hyperuricemia, glomerular filtration and cardiovascular diseases].
Topics: Coronary Artery Disease; Female; Humans; Kidney Diseases; Male; Metabolic Syndrome; Uric Acid | 2011 |
Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients.
Topics: Adult; Aged; Albuminuria; C-Reactive Protein; Coronary Artery Disease; Creatinine; Cross-Sectional S | 2011 |
Uric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes.
Topics: Adult; Analysis of Variance; Biomarkers; Blood Glucose; Coronary Artery Disease; Cross-Sectional Stu | 2011 |
Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography.
Topics: Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Death, Sudden, Cardiac; Fema | 2013 |
The relationship between inflammation and slow coronary flow: increased red cell distribution width and serum uric acid levels.
Topics: Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circulatio | 2011 |
Association between plasma levels of pigment epithelium-derived factor and renal dysfunction in patients with coronary artery disease.
Topics: Aged; Analysis of Variance; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Coronary Artery | 2011 |
Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men.
Topics: Atherosclerosis; Biomarkers; Body Mass Index; Calcinosis; Carotid Intima-Media Thickness; Coronary A | 2012 |
Serum gamma-glutamyltransferase concentration correlates with Framingham risk score in Koreans.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; C-Reactive Protein; Coronary Artery | 2011 |
Determinants of blood uric acid levels in a dyslipidemic Arab population.
Topics: Adult; Arabs; Body Mass Index; Chi-Square Distribution; Coronary Artery Disease; Cross-Sectional Stu | 2012 |
High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Disease | 2012 |
Predictors of clinical SYNTAX score in coronary artery disease: serum uric acid, smoking, and Framingham risk stratification.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Follow-Up Stud | 2011 |
Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort.
Topics: Adult; Black or African American; Coronary Artery Disease; Cross-Sectional Studies; Female; Follow-U | 2012 |
Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cause of Death; Coronary Artery Disease; Co | 2012 |
Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.
Topics: Adult; Alaska; Coronary Artery Disease; Female; Glomerular Filtration Rate; Humans; Hypertension; In | 2012 |
Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
Topics: Aged; Angina, Stable; Atorvastatin; Biomarkers; C-Reactive Protein; Case-Control Studies; Chi-Square | 2012 |
Association of uric acid with mortality in patients with stable coronary artery disease.
Topics: Adult; Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Female; Humans; Kaplan-Meier | 2012 |
Coronary artery dilation among patients with paediatric-onset systemic lupus erythematosus.
Topics: Adolescent; Body Mass Index; Child; Coronary Artery Disease; Coronary Vessels; Creatinine; Female; H | 2012 |
Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.
Topics: Aged; Biomarkers; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hum | 2013 |
Does uric acid qualify as an independent risk factor for cardiovascular mortality?
Topics: Biomarkers; Coronary Artery Disease; Diabetes Mellitus, Type 2; Humans; Hyperuricemia; Risk Factors; | 2013 |
Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: a prospective observational cohort study from the ET-CHD registry, 1997-2003.
Topics: Aged; Biomarkers; Cause of Death; Cohort Studies; Coronary Artery Disease; Female; Humans; Insulin R | 2013 |
Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production.
Topics: Acetylcholine; Animals; Arginase; Cell Line; Coronary Artery Disease; Down-Regulation; Endothelium, | 2013 |
Serum uric acid level is an independent risk factor for presence of calcium in coronary arteries: an observational case-controlled study.
Topics: Biomarkers; Case-Control Studies; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Risk F | 2013 |
Uric acid and prognosis in angiography-proven coronary artery disease.
Topics: Age Distribution; Aged; Biomarkers; Body Mass Index; Coronary Artery Disease; Epidemiologic Methods; | 2013 |
Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease?
Topics: Aged; Biomarkers; Chi-Square Distribution; Coronary Artery Disease; Female; Heart Failure; Humans; H | 2013 |
The role of hyperuricemia in coronary heart disease.
Topics: Coronary Artery Disease; Coronary Disease; Heart; Hematologic Diseases; Humans; Hyperuricemia; Uric | 1960 |
CORONARY ARTERY DISEASE IN NATAL INDIANS.
Topics: Aspartate Aminotransferases; Blood Chemical Analysis; Blood Pressure Determination; Cholesterol; Cor | 1964 |
CORONARY HEART DISEASE.
Topics: Blood Pressure; Cholesterol; Coronary Artery Disease; Coronary Disease; Geriatrics; Humans; Mass Scr | 1964 |
A FAMILY STUDY OF ISCHAEMIC HEART DISEASE.
Topics: Adolescent; Blood Chemical Analysis; Blood Pressure; Body Height; Body Weight; Child; Cholesterol; C | 1964 |
Influence of coronary artery disease risk factors on baroreflex sensitivity in the elderly.
Topics: Activities of Daily Living; Aged; Aging; Alcohol Drinking; Baroreflex; Blood Cell Count; Blood Gluco | 2003 |
Serum uric acid in relation to age and physique in health and in coronary heart disease.
Topics: Blood; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Humans; Uric Acid | 1951 |
Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation.
Topics: Adult; Aged; Allantoin; Coronary Artery Disease; Female; Homocysteine; Homocystine; Humans; Hyperhom | 2006 |
Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome.
Topics: Brazil; Coronary Artery Disease; Cross-Sectional Studies; Humans; Male; Metabolic Syndrome; Middle A | 2007 |
Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
Topics: Aged; Biomarkers; C-Reactive Protein; Calcinosis; Coronary Artery Disease; Coronary Disease; Coronar | 2007 |
Independent association of high serum uric acid concentration with angiographically defined coronary artery disease.
Topics: Aged; Biomarkers; Case-Control Studies; Coronary Artery Disease; Female; Humans; Hyperuricemia; Male | 2007 |
Birthweight and risk factors for cardiovascular diseases in Japanese schoolchildren.
Topics: Adiponectin; Birth Weight; Child; Coronary Artery Disease; Female; Humans; Infant, Newborn; Japan; M | 2007 |
Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Female; Humans; Ma | 2007 |
Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Coronary Artery Disease; Female; Genetic Predi | 2008 |
Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
Topics: C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Female; | 2008 |
Relationship between elevated levels of serum uric acid and saphenous vein graft disease.
Topics: Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Female; Graft Occlusion, Vasc | 2008 |
Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
Topics: Absorptiometry, Photon; Adult; Aged; Angina Pectoris; Angiography; Aorta, Abdominal; Aortic Aneurysm | 1994 |
Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
Topics: Adult; Aged; Anthropometry; Blood Glucose; Blood Pressure; C-Peptide; Comorbidity; Convalescence; Co | 1997 |
Serum urate and the risk of major coronary heart disease events.
Topics: Adult; Biomarkers; Cholesterol; Coronary Artery Disease; Coronary Disease; Humans; Male; Middle Aged | 1997 |
[The relationship between body mass index and coronary risk factors].
Topics: Adult; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Glucose Intoler | 1998 |
Serum uric acid levels in cardiovascular diseases.
Topics: Adult; Aged; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; Lipoproteins; Male; M | 1998 |
Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Coronary Artery Disease; Coronary Disease; Creatini | 1999 |
Morphologic correlation between atherosclerotic lesions of the carotid and coronary arteries in patients with angina pectoris.
Topics: Aged; Angina Pectoris; Arteriosclerosis; Blood Pressure; C-Reactive Protein; Carotid Artery Diseases | 1999 |
Insulin resistance and angiographical characteristics of coronary atherosclerosis.
Topics: Blood Pressure; Coronary Angiography; Coronary Artery Disease; Fibrinogen; Glucose Tolerance Test; H | 1999 |
Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Aged; Cohort Studies; Coronary Artery Disease; Female; Humans; Incidence; Male; Middle Aged; Prospec | 2000 |
Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease.
Topics: Adult; Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Female; Germany; Humans; Mal | 2002 |
Relationship between coronary risk factor and arteriographic feature of coronary atherosclerosis.
Topics: Adult; Aged; Cholesterol; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Fem | 1990 |
Simple carbohydrates in the diet.
Topics: Animals; Coronary Artery Disease; Diabetes Mellitus; Dietary Carbohydrates; Dietary Fats; Dietary Pr | 1987 |